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Among all the major infectious human diseases, gastro-intestinal infections caused 
by microbial pathogens are a major cause of morbidity and infant death in 
developing countries, largely due to inadequate sewage disposal and 
contaminated water. Traditional health practitioners in South Africa play a crucial 
role in providing health care to the majority of the population. Many plants are 
locally used by South African traditional healers to treat microbial infections related 
to gastro-intestinal tracts.  
 
Ethnopharmacological and ethnobotanical studies using traditional knowledge as a 
selection strategy has given priority to certain plants for isolation and identification 
of plant novel bioactive compounds. Pharmacological and phytochemical studies 
of the investigated twelve medicinal plant species (from 10 families) extensively 
used as antimicrobials against gastro-intestinal infections was necessary to 
validate the use of the plants. Furthermore, to provide sufficient preliminary 
information for the isolation and identification of active compounds that are present 
in the investigated plants.  
 
Plant parts were sequentially extracted using petroleum ether (PE), 
dichloromethane (DCM) and 70% ethanol (EtOH). Cold water and boiled 
(decoction) extracts of the plant materials were prepared non- sequentially. Among 
the extracts, EtOH yielded the highest amount of plant substances. A total number 
of 85 extracts were evaluated for antibacterial activity, 80 for antifungal activity, 64 
for anti-inflammatory activity, and 27 biologically active extracts were tested for 
genotoxicity.  
 
The microdilution method was used to determine the minimum inhibitory 
concentration values in the antibacterial assay against two Gram-negative bacteria 
(Escherichia coli ATCC 11775 and Klebsiella pneumoniae ATCC 13883) and two 
Gram-positive bacteria (Bacillus subtilis ATCC 6051 and Staphylococcus aureus 
ATCC 12600). A modified microdilution method was used to determine the 
minimum inhibitory concentration (MIC) and minimum fungicidal concentration 
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(MFC) values in the antifungal assay against Candida albicans. Cyclooxygenase 
assay was used to evaluate the anti-inflammatory activity of the extracts against 
cyclooxygenase-1 and -2 (COX-1 and COX-2) enzymes. The plant extracts were 
screened first at a concentration of 250 µg/ml per test sample, and then further 
screened at concentrations of 125 and 62.5 µg/ml for extracts that inhibited the 
COX-2 enzyme. The Ames test was used to test for genotoxicity in extracts that 
showed interesting pharmacological activities using Salmonella typhimurium strain 
TA98.  
 
Among the screened extracts, 25 extracts showed good antibacterial activity with 
MIC values ≤ 1.0 mg/ml. Dichloromethane extracts exhibited the greatest 
antibacterial activity, and Gram-positive bacteria were most susceptible. The best 
antibacterial activity was exhibited by Becium obovatum leaf EtOH extracts with an 
MIC value of 0.074 mg/ml. A broad spectrum antibacterial activity was observed 
by leaf extracts of Cucumis hirsutus (PE), Haworthia limifolia (PE), Protea simplex 
(PE and DCM) and Dissotis princeps (EtOH) against both Gram-negative and 
Gram-positive bacteria. No interesting antibacterial activity was exhibited by water 
extracts with the exception of Dissotis princeps water extract with a good 
antibacterial activity against Gram-positive and Gram-negative bacteria. In the 
antifungal assay, 6 extracts showed interesting antifungal activity. Protea simplex 
leaf PE extract showed the best fungicidal activity with an MFC value of 0.014 
mg/ml. The best overall antifungal activity was observed in plant EtOH extracts. 
Some extracts from Agapanthus campanulatus (leaves and roots), Dissotis 
princeps (leaves), Gladiolus dalenii (corms) and Protea simplex (leaves) showed 
good activity against Candida albicans.  
 
Twenty one extracts inhibited the COX-1 enzyme, while fifteen extracts inhibited 
the COX-2 enzyme at the lowest screening concentration of 62.5 µg/ml. The 
highest COX-1 inhibition at a concentration of 62.5 µg/ml was exhibited by 
Diospyros lycioides leaf PE extract (89.1%) while Agapanthus campanulatus root 
DCM extract showed the highest COX-2 inhibitory activity (83.7%) at the same 
concentration. In the Ames test, no genotoxicity was observed in any of the 
extracts, however more tests need to be done to confirm these results.  
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Thin layer chromatograms of the organic solvent plant extracts were developed. 
The fingerprints of the plant extracts showed colours of bands at different Rf values 
when viewed under UV254 and UV366 suggesting that the investigated plant species 
contained different compounds in the extracts.  
 
In the quest to understand the source of the plants pharmacological activities, total 
phenolic compounds including condensed tannins, gallotannins and flavonoids 
were quantitatively investigated in terms of their amounts in the aqueous methanol 
extracts of the plants materials using spectrophotometric methods. Alkaloids and 
saponins were qualitatively determined. The amounts of total phenolics were 
determined by the Folin Ciocalteu assay, condensed tannins were determined by 
the butanol-HCl assay, while rhodanine and vanillin assays were used to 
determine the amounts of gallotannins and flavonoids respectively. Dragendorff 
reagent was used to detect alkaloids in the plant extracts on thin layer 
chromatographic plates, while the froth test was employed to detect saponins. 
Secondary metabolites varied with plant parts and species with Cyperus textilis 
(leaf) having the highest amounts of total phenolics, condensed tannins and 
flavonoids. The highest amount of gallotannins was detected in Protea simplex 
leaf extracts. All the investigated plant materials with the exception of Haworthia 
limifolia leaf, Protea simplex leaf, Antidesma venosum leaf and Dissotis princeps 
leaf tested positively to saponins. Alkaloids were detected in Haworthia limifolia 
leaf (PE and EtOH), Cucumis hirsutus leaf (EtOH), Becium obovatum root (DCM), 
Protea simplex root and bark (EtOH), Agapanthus campanulatus root (DCM) and 
leaf (EtOH), Cyperus textilis root (DCM), Vernonia natalensis leaf (PE), Antidesma 
venosum leaf (PE), Diospyros lycioides leaf (PE) and Dissotis princeps leaf (DCM) 
extracts.  
 
The results obtained from the investigation of the pharmacology and 
phytochemistry of the plant species used to treat microbial infections related to 
gastro-intestinal tracts, provide sufficient preliminary information to validate the 
use of some of the plants in traditional medicine. The information provided might 
be considered sufficient for further studies aimed at isolating and identifying the 
active compounds in the plant species, and evaluating possible synergism 
amongst the isolated compounds. 
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Plants have been used as the basis of many traditional medicine systems 
throughout the world for thousands of years. They continue to provide mankind 
with new remedies. Fossil records date human use of plants as medicines at least 
to the middle Palaeolithic age some 60,000 years ago (SANJAY and ARVIND, 
2007). 
 
According to the World Health Organisation (WHO) the definition of traditional 
medicine is the sum total of all the knowledge and practical experience used in the 
diagnosis, prevention and elimination of physical, mental or social imbalance. This 
knowledge is handed down from generation to generation verbally or in writing 
(BANNERMAN et al., 1983; LEWIS and ELVIN-LEWIS, 2003). 
 
Every region has its own history of traditional medicine, for example traditional 
Chinese medicine (TCM), Arabic traditional medicine and African traditional 
medicine. Such practices are traditional because they are deeply rooted in a 
specific socio-cultural context, which varies from one community to another. Each 
community has its own particular approach to health and disease even at the level 
of ethno-pathogenic perceptions of diseases and therapeutic behaviour 
(RUKANGIRA, 2001). 
 
In Africa, herbal medicine is gaining popularity as alternative and complementary 
therapies, largely as a result of cultural traditions and excessive cost of modern 
medicines. Traditional remedies made from plants play an important role in the 
health of millions of people. Low-income people such as subsistence farmers, 
people of small isolated villages and native communities use folk medicine for the 
treatment of common infections (ROJAS et al., 2006). 
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1.2 African Traditional Medicine 
 
Infectious diseases account for approximately one-half of all deaths in tropical 
countries due to drug resistant micro-organisms and the emergence of unknown 
disease-causing microbes. In Africa, up to 80% of the population use traditional 
medicine for primary health care (SOFOWORA, 1993).  
 
Medicinal plants are considered as wild plants though most can be cultivated 
(COETZEE et al., 1999; HAOREAU and DASILVA, 1999). Plants have been 
used in African traditional medicine for centuries against a variety of diseases 
(GILLS and AKINWUMI, 1986). Plants of medicinal values include trees, shrubs, 
tubers, creepers and climbers that have healing properties. Medicinal plants are 
not only used by traditional practitioners to treat diseases attributed to both 
naturalistic and supernatural causes but also serve as ingredients in performing 
rituals or mystic practices (OLIVER-BEVER and  ZAHND, 1979).   
 
AMPOFO and JOHNSON-ROMAULD, (1978) defined a traditional healer as a 
person who is recognised by the community in which he or she lives as competent 
to provide health care using herbs, animals, mineral substances and some other 
methods based on social, cultural knowledge such as attitudes, as well as beliefs 
that are prevalent in the community regarding physical, mental and social well-
being.  
 
How and why people select particular plants for medicinal purpose is based on 
observations of what happened to animals or persons who had eaten certain 
plants accidentally. In other cases, it was noticed that plants produced some 
secretions which had relieving effects on itching skin or cleared up a sore on a 
person who touched the plant. Such observations suggest that the selection of 
specific plants is not solely a function of availability but the accumulated traditional 
medicinal knowledge of healing that had been passed on and developed from 
generation to generation (BEP, 1986; ETKIN, 1986). 
 
Traditional medicine in Africa plays a significant role in human health with the use 
of medicinal plants which are active against a wide variety of human pathogens 
having shown great promise in the treatment of intractable infectious and life 
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threatening diseases including malaria, tuberculosis, and opportunistic diseases in 
HIV patients (IWU et al., 1999). Over the past two decades WHO has encouraged 
the use of traditional medicine, especially in developing countries by promoting the 
incorporation of its useful elements into national health care systems (ISAAC et 
al., 1995). 
 
In Zimbabwe, traditional healers are consulted on a large variety of health 
problems (McIVOR, 1989). HEDBERG et al. (1982) observed that the number of 
traditional medicinal practioners in Tanzania was estimated to be 30 to 40,000 in 
comparison with 600 medicinal doctors.  
 
 
1.3 Traditional Medicine in South Africa 
 
South Africa is blessed with a rich plant biodiversity of more than 24,000 
indigenous plants, representing about 10% of all higher plants on Earth. The 
country has a long tradition of medicinal use of plants. It is estimated that at least 
70% of all South Africans consult one of the more than 200,000 traditional healers 
in the country. Between 12 and 15 million South Africans still depend on traditional 
herbal medicines (MEYER et al., 1996; WHO, 2001). Traditional medicine which is 
an integral part of South African cultural life is not likely to change to any 
significant degree in years to come (BRANDT et al., 1995). 
 
Traditional health practitioners in South Africa thus play a crucial role in providing 
health care to the majority of the population. In most cases, they are the first 
health care providers to be consulted, especially in rural areas where the practice 
is deeply interwoven into the fabric of cultural and spiritual lives of the people. It is 
for this reason that there is a wide recognition of traditional medicine practices in 
South Africa (WHO, 2001). Traditional healers in South Africa make use of several 
species of medicinal plants, differing with ethnic groups for the treatment of 
various ailments in both humans and domestic animals. With the ratio of medical 
doctors to patients in South Africa being 1:17,400, traditional medicine forms an 
important component in the nation’s health care system (PRETORIUS et al., 
1993). The use of traditional medicine is not only confined to rural, low income 
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groups but is often used for treating conditions irrespective of education and 
income levels (COCKS, 1997; MARSHALL, 1998; COCKS and DOLD, 2000). 
 
 
1.4 Trade of Medicinal Plants  
 
Medicinal and aromatic plants play a significant role in meeting the demands of the 
traditional medicine markets which are found both domestically and in international 
markets (TITZ, 2004). They are usually traded as whole plant or plant parts 
(chopped) normally in dried form. In a few cases, they are traded fresh or 
preserved in alcohol (LANGE, 1998). In producer countries, plant materials are 
bought from collectors, cultivators, local dealers or district traders. They are then 
passed on to wholesalers, manufacturers or directly to retailers. The wide range of 
manufacturers involved can include those engaged in the production of 
pharmaceuticals, research laboratories, cosmetics, foods and colouring agents 
(LANGE, 1998). The largest global markets for medicinal plants exist in China, 
France, Germany, Italy, Japan, Spain, and the United Kingdom. Japan has the 
highest per capita consumption of botanical medicines in the world (GLASER, 
1999; LAIRD, 1999). 
 
In addition to the markets for medicinal plants, there is an expanding market in 
developed countries for botanical based products, such as health foods and 
supplements, herbal drinks and various health and personal care products. The 
market for herbal products throughout the world is currently worth an estimated 
US$60 billion per annum with a growth rate of 7 percent (WHO, 2003; TITZ, 2004).  
 
The German phytomedical market grew at 30 percent between 1993 and 1995, 
from a value of US$2.5 billion to US$3.26 billion. The estimated growth rate in 
1998 to 1999 was 5 to 10 percent (LANGE, 1998). Turkey is reported to export 
approximately 28,000 tonnes of medicinal and aromatic plants annually, 
generating nearly US$50 million (OZHATAY et al., 1998). 
 
There has been substantial growth in herb and herbal product markets across the 
world in the last three decades. Rapidly rising exports of medicinal plants during 
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the past decade testifies to worldwide interest in these products as well as in 
traditional health systems (SRIVASTAVA, 2000). 
 
In South Africa, the trade in traditional medicines forms part of a multi-million rand 
revenue due to high cultural value of traditional medicines. Demand generates a 
species specific trade network that extends across national boundaries 
(CUNNINGHAM, 1997). There are an estimated 27 million indigenous medicine 
consumers in South Africa with a large supporting industry (MANDER, 1998). 
More than 700 plant species are known to be actively traded for medicinal 
purposes throughout the country (DOLD and COCKS, 2002). To date, most 
documentation of the trade in medicinal plants has been undertaken in the Eastern 
Cape, Gauteng, KwaZulu-Natal and Mpumalanga provinces of South Africa. This 
evidently suggests that the trade in medicinal plants is not only local but also inter-
provincial (DAUSKARDT, 1990; WILLIAMS, 1996; MANDER, 1997; WILLIAMS 
et al., 1997; MANDER, 1998; WILLIAMS et al., 2000). 
 
 
1.5 Ethnopharmacology Approach to Discovery of Novel Medicinal Drugs 
 
Ethnopharmacology is an interdisciplinary area of research that deals with the 
identification, description, observation and investigation of ingredients used in 
various recipes of traditional medicine and their effect on animal models. It also 
studies the relevant forms of indigenous knowledge, practice and cultures 
implementing the ingredients (JANARDHANAN and GEORGE, 2006). 
 
Nature is the best combinatorial chemist and possibly has answers to all diseases 
of mankind. Until now, natural compounds discovered from medicinal plants and 
their analogues have provided numerous clinically useful drugs. The fact that only 
about one-tenth of the flowering species occurring globally had been investigated 
for their pharmaceutical potential suggests that medicinal plants could be a major 
potential source of compounds for the treatment of human diseases, including HIV 
infection (SANJAY and ARVIND, 2007). 
 
Screening of more medicinal plants for antimicrobial activities and phytochemicals 
is important for finding potential new compounds for therapeutic uses. The 
6 
 
research based on ethnopharmacological information is generally considered an 
effective approach in the discovery of new anti-infective agents from higher plants 
(KLOUCEK et al., 2005). 
 
The use of plants in modern medicines involves the isolation of active compounds. 
This commenced with the isolation of morphine from opium in the early 19th 
century (KINGHORN, 2001). Subsequently this led to the isolation of early drugs 
such as cocaine, codeine, digitoxin and quinine, some of which are still in use 
today (NEWMAN et al., 2000; BUTLER, 2004).  
 
Drug discovery from plants has evolved to include numerous interdisciplinary fields 
and various methods of analysis. The process typically begins with a botanist, 
ethnobotanist, ethnopharmacologist, or plant ecologist who collects and identifies 
the plants of interest. Collection may involve species with known biological activity 
for which active compound(s) have not been isolated or may involve taxa collected 
randomly for a large screening programme (SANJAY and ARVIND, 2007).  
 
As drug discovery from plants has traditionally been time-consuming, faster and 
better methodologies for plant collection, bioassay screening, compound isolation 
and compound development are now being employed (KOEHN and CARTER, 
2005). The entire processes of new drug discovery from medicinal plants undergo 
a series of scientific stages before the drug can be commercially produced. These 
steps include, formulating an appropriate strategy, obtaining biologic extracts, 
screening those extracts, isolating active compounds, conducting preclinical tests 
and chemical modification, and commencing commercial production (ARTUSO, 
1997). In spite of the various challenges encountered in medicinal plant-based 
drug discovery, natural products isolated from plants still remain an essential 
component in the search for new medicines.  
 
 
1.6 Drugs Discovered from Medicinal Plants  
 
Numerous methods have been utilized to acquire compounds for drug preparation, 
this include isolation from plants and other natural sources, synthetic chemistry, 
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combinatorial chemistry and molecular modelling (GEYSEN et al., 2003; 
LOMBARDINO and LOWE, 2004).  
 
It is estimated that 61% of the 877 small-molecule new chemical entities 
introduced as drugs worldwide during 1981 to 2001 were inspired by natural 
products (NEWMAN et al., 2003).  In addition to the biologically active plant-
derived secondary metabolites which have found direct medicinal application as 
drug entities, many other bioactive plant compounds have proven useful as model 
compounds for drug syntheses or semi-syntheses.  
 
Natural compounds of pharmaceutical importance that were once obtained from 
higher plant sources, but which are now produced commercially largely by 
synthesis, include caffeine, theophylline, theobromine, ephedrine, 
pseudoephedrine, papaverine, L-dopa, salicylic acid, and ∆-tetrahydrocannabinol 
(KINGHORN and BALANDRIN, 1993). A guanidine-type alkaloid, galegine, was 
found to be the active principle of Galega officinalis L., and is used clinically for the 
treatment of diabetes (SNEADER, 1985). 
 
Recently, several new medicinal plant-derived drugs have been introduced to the 
U.S.A market. Arteether is a potent anti-malarial drug and is derived from 
artemisinin, a sesquiterpene lactone isolated from Artemisia annua L. 
(Asteraceae), a plant used in traditional Chinese medicine. Other derivatives of 
artemisinin are in various stages of use or clinical trials as anti-malarial drugs in 
Europe (VAN AGTMAEL et al., 1999; GRAUL, 2001). 
 
Galantamine is a natural product discovered through an ethnobotanical lead and 
first isolated from Galanthus woronowii Losinsk (Amaryllidaceae) in Russia in the 
early 1950s. Galantamine is now approved for the treatment of Alzheimer’s 
disease. It slows the process of neurological degeneration by inhibiting 
acetylcholinesterase as well as binding to and modulating the nicotinic 
acetylcholine receptor (HEINRICH and TEOH, 2004; PIRTTILA et al., 2004).  
 
Nitisinone is a newly released medicinal plant-derived drug that works on the rare 
inherited disease, tyrosinaemia, demonstrating the usefulness of natural products 
as lead structures (FRANTZ, 2005). Nitisinone is a modification of mesotrione, an 
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herbicide based on the natural product leptospermone, a compound isolated from 
Callistemon citrinus Stapf. (Myrtaceae) (MITCHELL et al., 2001). Nitisinone 
inhibits enzyme 4-hydroxyphenylpyruvate dehydrogenase (HPPD), in humans and 
maize (HALL et al., 2001; MITCHELL et al., 2001). Inhibition of the HPPD 
enzyme in maize acts as an herbicide and results in reduction of plastoquinone 
and tocopherol biosynthesis, while in humans the HPPD enzyme inhibition 
prevents tyrosine catabolism and the accumulation of toxic bioproducts in the liver 
and kidneys (HALL et al., 2001). 
 
Tiotropium has recently been released to the United States market for treatment of 
chronic obstructive pulmonary disease (MUNDY and KIRKPATRICK, 2004; 
FRANTZ, 2005). Tiotroprium is an inhaled anticholinergic bronchodilator, based on 
ipratropium, a derivative of atropine that has been isolated from Atropa belladonna 
L. (Solanaceae) and other members of the Solanaceae family (BARNES et al., 
1995; DEWICK, 2002; MUNDY and KIRKPATRICK, 2004). Tiotropium has shown 
increased efficacy and longer lasting effects when compared with other available 
chronic obstructive pulmonary disease medications (BARNES, 2002; MUNDY and 
KIRKPATRICK, 2004). There are numerous other plant-derived drugs that are 
currently undergoing clinical tests. 
 
 
1.7 Conservation of Medicinal Plants 
The demand for medicinal plants in developing countries has been met by 
indiscriminate harvesting of flora including those in forests. This is due to the lack 
of conservation knowledge among traditional healers and other harvesters. As a 
result, many plant species have become extinct and some are endangered or 
threatened (JOHN, 2006). 
The African continent is estimated to have about 2,163,400 hectares of closed 
forested areas. With a calculated annual loss of about 1% due to deforestation, 
some of the medicinal plants and other genetic materials may become extinct 
before they are even documented. Research has shown that the massive demand 
for bark, roots, and whole plants from wild populations is causing a critical decline 
in population numbers of some species, and may lead to numerous extinctions. 
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Africa has one of the highest rates of deforestation in the world with Cote d’Ivore 
and Nigeria having 6.5% and 5.0% deforestation rates per year respectively 
compared against a global rate of 0.6% (RUKANGIRA, 2001). 
Increasing harvesting pressure on traditional supply areas are linked to a growing 
shortage in supply of popular medicinal plant species. At greatest risk of extinction 
are slow growing, popular and commonly used species that have a limited 
distribution.  Demand for certain taxa exceeds supply, with traders reporting acute 
shortages and price increases. Several plant species have been greatly exploited 
by traditional healers, some of these plant species are therefore considered being 
vulnerable because they are only found in protected areas (DOLD and COCKS, 
2002). 
Concern about this problem has brought conservationists and resource users 
together to investigate possible solutions (COLLINS, 2001). This can be done 
through the establishment of medicinal plant gardens and farms. For sustainable 
harvesting, plant part substitution is a means of alleviating the pressure placed on 
highly popular medicinal plants. For example, because of the destructive 
harvesting nature of underground or bark plant parts, the use of leaves should be 
encouraged if they contain and or provide the same active compounds. 
Conservation and cultivation of medicinal plants primarily in community gardens 




1.8 Major Infectious Diseases of Humans 
 
Only a small proportion of the micro-organisms that abound in nature are 
pathogenic to man. Most are free-living in soil, water and similar habitats, and are 
unable to invade the living body (GREENWOOD et al., 1992).  According to 
SLEIGH and TIMBURY (1998), major microbial infections in humans are 
infections of the upper respiratory organs, gastro-intestinal tract, skin, urinary tract, 




Among all these major infectious diseases, gastro-intestinal microbial infections 
are a major cause of morbidity and infant death in developing countries, largely 
due to inadequate sewage disposal and contaminated water. Well over 500 million 
episodes of diarrhoea as a result of gastro-intestinal infections in children under 
five are estimated to occur annually in Asia, Africa, and Latin America. At least five 
million children die due to such disorders (WHO, 1996; BARBARA, 1998). Some 
of the causes of gastro-intestinal microbial infections include viruses, bacteria, 
bacterial toxins, fungi and protozoa. Gastro-intestinal microbial infection 
(gastroenteritis) is an illness triggered by the infection and inflammation of the 
digestive system particularly the stomach and intestine. It is frequently referred to 
as stomach or intestinal flu. Gastroenteritis is characterized by loss of appetite, 
bloating, nausea, vomiting, abdominal cramps and pains, bloody stools, pus in the 
stools, and is accompanied by fever and overall weakness (BARBARA, 1998). 
 
Infectious gastroenteritis typically lasts about three days if well treated. Adults 
usually recover without difficulty, but children, the elderly, and or HIV patients with 
an underlying disease are more vulnerable to complications such as dehydration 
and even death if proper medical attention is not employed. Clinically, the 
secretion and absorption processes in the small and large intestines are disrupted 
resulting in dehydration (GERALDINE and KELLY, 2007). Dysentery caused as a 
result of intestinal infections is described as the configuration of fever, pain, and 
bloody diarrhoea. Diarrhoea accounts for approximately 80% of microbial gastro-
intestinal infections in humans (BARBARA, 1998; BHAN, 2000). 
 
Infectious gastroenteritis is caused by many bacterial species such as Shigella 
species, Vibro cholerae, Escherichia coli, Staphylococcus aureus, Bacillus 
species, Salmonella species, Klebsiella species, and Campylobacter species. 
Other pathogens that invade the mucosa and produce cytotoxins or primarily affect 
the colon in patients suffering from gastro-intestinal infections include Entamoeba 
histolytica, Candida albicans, Giardia lamblia, Cryptosporidium and Cyclospora 
(ROBERT et al., 1990; SLEISENGER and FORDTRAND, 1993; BURTON and 
ENGELKIRK, 1995; SLEIGH and TIMBURY, 1998; NIYOGI et al., 2000; 
ADEGUNLOYE, 2006). Patients with inflammatory gastroenteritis are typically 
more ill, with higher fever and more severe abdominal pain or cramp. Non-
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inflammatory gastroenteritis causes watery diarrhoea of larger volume, resulting 
from the attack of the intestinal walls by viruses such as Rotavirus, Adenovirus 
and Astrovirus. Severe loose stools usually result in loss of about 10% of total 
body weight or 250 millilitres per kilogram per day or more (KEUSCH et al., 1992; 
BARBARA, 1998; SLEIGH and TIMBURY, 1998). Dehydration as a result of 
diarrhoea may also cause decreased skin elasticity, absent tears, dry mucous 
membranes, sunken eyes, decreased urine output and abnormal pains 
(GERALDINE and KELLY, 2007). 
 
The organisms or toxins responsible for gastro-intestinal infections are readily 
transmitted via food, water, environmental contacts, pets, and from person to 
person, with morbidity rates in developing countries three-fold higher than in the 
developed countries as a result of poor sanitation, malnutrition, drinking of unclean 
water, poor living conditions and lack of access to vaccines that protect against 
diarrhoeal pathogens in poor and remote communities (RYAN and 
CALDERWOOD, 2000; GUERRANT et al., 2001). 
 
According to KRAMER and CHALMERS (2001), there are a few steps that can be 
taken to prevent microbial gastro-intestinal infections. Exclusive breast feeding can 
reduce gastroenteritis in infants by 40% as breast milk build strong immunity in 
infants against diarrhoeal pathogens. Furthermore, household treatment of water 
and consumption of uncontaminated water are associated with a 39% reduction in 
diarrhoea incidence. Food poison can be prevented by ensuring that foods are 
well-cooked and uncontaminated before they are consumed. Children are at 
particular risk where faeces are disposed at ground level. It is reported that 
sanitation interventions produce a 32% reduction in diarrhoea incidence. Hygienic 




1.9 Aims and Objectives 
 
Gastro-intestinal microbial infections account for 40% of deaths among children 
under the ages of five in rural areas, and it is also one of the opportunistic 
diseases in HIV patients with a direct cause of death in many children.  There are 
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many plants that are used by South African traditional healers in the treatment of 
many microbial infections and the associated symptoms. The aim of the study was 
to pharmacologically evaluate some traditional medicinal plants locally used for the 
treatment of gastro-intestinal microbial infections for antibacterial and antifungal 
activities against some gastro-intestinal pathogens using in vitro microdilution 
bioassays. The anti-inflammatory activity was also determined to know how 
effectively the plants alleviate stomach and intestinal pains as well as cramps that 
are often associated with gastroenteritis in humans. Plant extracts showing good 
antimicrobial activities were subjected to genotoxicity testing to establish how safe 
it is to use the plant material. Furthermore, in order to understand the source of the 
plant biological activities, total phenolic compounds including condensed tannins, 
gallotannins and flavonoids were quantitatively investigated in terms of their 
amounts in the aqueous methanol of the plant materials using spectrophotometric 
methods. Alkaloids and saponins were qualitatively determined. 
 
The output of the research work will later assist in the isolation and identification of 
active compounds that are present in the medicinal plants for the development of 




















COLLECTION AND EXTRACTION OF PLANT MATERIAL 
 
 
2.1 Materials and Methods 
 
2.1.1 Collection of Plant Material 
 
The selection of medicinal plants was based on the indigenous ethno-
pharmacological records compiled by different researchers on the use of the 
medicinal plants by various South African tribes. Twelve traditional medicinal 
plants that have not been investigated but extensively used for the treatment of 
gastro-intestinal microbial infections and other related problems (Table 2.1) were 
collected from Mt. Gilboa (29º 16.766' S, 30º 17.627' E), Midmar (29º 29.703' S, 
30º 12.417' E), the University of KwaZulu-Natal botanical garden and 
Pietermaritzburg National Botanical Garden in KwaZulu-Natal Province, South 
Africa. Due to availability and consideration of potential sustainable harvesting of 
medicinal plants, the leaves of some plant species were substituted for their roots. 
Voucher specimens were identified and lodged in the University of KwaZulu-Natal, 
Pietermaritzburg Herbarium. Different parts of the collected medicinal plants were 
oven-dried at 50 ºC, ground into powder and stored in airtight containers at room 
temperature in the dark until they were required for extraction. 
 
 
2.1.2 Extraction of Plant Material 
 
Ground plant material (5 g of each plant sample) was sequentially extracted with 
100 ml of solvents; petroleum ether (PE), dichloromethane (DCM) and 70% 
ethanol (EtOH) in a sonication bath (Julabo GMBH sonicator) for 1 h at room 
temperature. Ice was added to water in the sonicator to cool the plant material. 
Water extracts were prepared non-sequentially. All the extracts were filtered under 
vacuum through Whatman No.1 filter paper in Bϋchner funnels. Water extracts 
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were freeze-dried while organic extracts were concentrated in vacuo with a 
Bϋchner rotary evaporator at 30 ºC. The resultant extracts were transferred to 
weighed pill vials and placed under a stream of air for complete dryness. Dried 
extracts were kept in the dark at 10 ºC until required.  
 
 
2.1.3 Preparation of Extracts from Boiled Medicinal Plants 
 
Ground plant material (5 g of each plant sample) was added into 20 ml of distilled 
water (pH 7), and then placed on a hot stove regulated at 100 ºC. The plant 
material was allowed to boil in water for 15 min before being removed from the 
stove and allowed to cool to room temperature. The resultant extract was filtered 
in vacuo through Whatman No.1 filter paper and freeze-dried. Dried extract was 
weighed and stored in the dark at 10 ºC until required. 
 
 
2.1.4 Percentage Yield of Dried Extracts 
 
In order to establish the amount of dried crude extract obtained from the extraction 
of dried plant sample in each solvent, the percentage yield of the dried extracts 
was calculated (Table 2.2). The percentage yield was represented as the 














2.2 Results and Discussion 
 
Table 2.1: Traditional medicinal plants used for the treatment of gastro-
intestinal microbial ailments in South Africa 
Species, (Family)   
Voucher number¹ ,  Plant part evaluated² 
 
Ethnopharmacological information  
Agapanthus campanulatus Leighton  (Agapanthaceae) 
FAW 4 NU,     LF & RT 
Root decoctions are taken orally or as 
enemas to ensure that a child is free 
from stomach trouble (WATT and 
BREYER-BRANDWIJK, 1962). 
 
Antidesma venosum  E. Mey.ex Tul. (Euphorbiaceae)  
FAW 7 NU,     LF 
 
Leaf decoctions are used for abdominal 
disorders and dysentery (HUTCHINGS 
et al., 1996). 
 
Becium obovatum E. Mey. Ex Benth. (Lamiaceae)  
FAW 8 NU,    LF & RT 
Warm water infusions of pounded roots 
and leaves are administered as 
enemas to treat children with stomach 
ailments and abdominal pain 
(POOLEY, 1998). 
Cucumis hirsutus Sond  (Cucurbitaceae)  
FAW 2 NU,   LF 
 
Leaf and root decoctions are used for 
abdominal pain and diarrhoea 
(HUTCHINGS et al., 1996). 
Cyperus textiles Thunb. (Cyperaceae)  
FAW 9 NU,     LF & RT 
 
Root infusions are used as enemas to 
children with various stomach ailments 
(HUTCHINGS et al., 1996). 
Diospyros lycioides Desf. (Ebenaceae)  
FAW 10 NU,    LF & ST 
Bark and root decoctions are taken for 
bloody faeces and dysentery 




¹Voucher number: NU = Natal University, Pietermaritzburg campus Herbarium. 
²Plant part evaluated: BK= Bark, CM= Corm, LF = Leaf, RT= Root, ST= Stem. 
 
Dissotis princeps  (Kunth) Triana (Melastomataceae)  
FAW 11 NU,     LF 
 
Leaf infusions are administered as 
enemas for dysentery and diarrhoea 
(HUTCHINGS et al., 1996). 
 
Gladiolus dalenii van Geel (Iridaceae) 
FAW 12 NU,   CM 
 
Corm ground down to a fine meal and 
taken with warm water in small 
quantities to treat dysentery, diarrhoea 
and stomach upsets (ROBERTS, 
1990). 
Haworthia limifolia Marloth  (Asphodelaceae)  
FAW 3 NU,    LF 
Decoction made from the leaves is 
used for stomach trouble (HUTCHINGS 
et al., 1996). 
Protea simplex E. Phillips  (Proteaceae)  
FAW 1 NU,   LF & BK 
 
Decorticated root infusions are used for 
dysentery and diarrhoea in humans and 
calves (HUTCHINGS et al., 1996). 
Vernonia natalensis Sch.Bip. e x Walp. (Asteraceae)   
FAW 6 NU,   LF 
 
Decoctions from leaves and stems are 
used for stomach cramps, nervous 
spasms of the stomach and other 
stomach ailments (HUTCHINGS et al., 
1996). 
 
Watsonia tabularis Bak  (Iridaceae)  
FAW 5 NU,   CM 
 
Corms are used for diarrhoea in 




2.2.1 Extraction of Plant Material 
 
Extraction of bioactive compounds from medicinal plants is to a great extent, 
dependent on the surface area of the material to be extracted and the extracting 
solvents used in the extraction. The surface area of plant materials is increased by 
grinding the dried plant materials to powders in order to enhance the penetration 
of the extracting solvents into the cell components of the plant materials, thereby 
increasing the yield of biological compounds present in them. According to ALBU 
et al. (2004), sonication has been proven to increase the yield of compounds from 
plant material. It also reduces extraction time. Ice was added to cool the 
temperature of the plant material during sonication so as to prevent breakdown of 
thermolabile biological compounds in the plant material   (ELOFF, 1998).   
 
Polar and non-polar biological compounds readily dissolve in polar and non-polar 
solvents respectively. The extracting solvents (PE, DCM, EtOH and water) were 
used because of their wide polarity range. This ensured that majority of the plant 
compounds were extracted in at least one of the extracting solvents. A sequential 
extraction method was employed in order to possibly have different biological 
compounds or different amounts in each of the solvent extracts. The water 
extracts were prepared non-sequentially in order to imitate the extraction or 
preparation techniques in traditional medicine. The extracts were kept in the dark 
at 10 ºC to prevent or reduce growth of any phototropic micro-organism on the 




 2.2.2 Preparation of Extract from Boiled Medicinal Plants 
 
In traditional medicine systems, herbal remedies are prepared in several but rather 
standardized ways which usually vary based on the plant utilized, and sometimes, 
the kind of condition or disease to be treated. Some of these methods include 
infusions (hot teas), decoctions (boiled teas), tinctures (alcohol and water 
extracts), and macerations (cold-soaking) (JEAN, 1990). In South Africa, most of 
the medicinal plants are prepared by infusion and decoction (HUTCHINGS et al., 
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1996). Boiling of medicinal plants in this study is a close imitation of plant extract 
preparation in traditional medicine. It also helped to determine the effects heat had 

































Table 2.2: Dried residues yielded from the extraction of dried plant materials 





 Percentage yield per extract 






























































































































Protea simplex Leaves 0.4 0.2 24.8 12.6 17.3 













2.2.3 Percentage Yield of Dried Extracts 
 
For most plant species, EtOH extracted the largest quantity of plant substances, 
while boiled plant materials better yielded substances compared with water 
extracts (Table 2.2).  Relatively, small yields were obtained with DCM and PE. 
According to EVANS (1996), alcohol is a general solvent and tends to provide a 
more complete extraction of compounds with a variety of polarities. Larger amount 
of yields obtained with EtOH could be as a result of its affinity to extract many 
plant substances particular polar compounds present in the plant materials. Plant 
substances obtained in decocted (boiled) plant materials could probably be due to 
the solubility effect of heat that better breakdown cellular membranes and 
components of the plant materials.  
 
 
 2.3 Conclusions 
 
The extraction of all possible active principles from medicinal plants for 
pharmacological evaluation is to some extent dependent on the solvents used in 
the extraction method. In extracts where good biological activity is observed, it will 
help to know possible suitable solvent combinations to use for the isolation of 
active compounds that may be responsible for the biological activity. The use of 
scientific methods in the preparation of traditional medicinal plants is effective in 














EVALUATION OF ANTIBACTERIAL ACTIVITY IN 
INVESTIGATED PLANT  EXTRACTS 
 
 
3.1   Introduction  
 
Bacterial diseases are still widespread and common, but its spectrum is changing 
because diseases which were once familiar are now rare and new infections are 
being recognized (SLEIGH and TIMBURY, 1998). Food poisoning as a result of 
bacterial contamination is one of the major microbial infections which are now 
being reported in many parts of the world, particularly in Australia, Canada, Japan, 
South Africa, USA, European countries, and in most African countries (BAUMLER 
et al., 2000; ADAK et al., 2002). A major concern with regards to gastro-intestinal 
bacterial infections is the alarming increase of antimicrobial resistance of key 
causative species (BAR-MEIR et al., 2005).  
  
 
3.1.1 Gastro-intestinal Bacterial Infections 
  
Diarrhoea which is a major symptom of gastro-intestinal infection is one of the 
leading causes of death in most developing countries; its greatest impact is seen 
in infants and children. In the United States, there is an average of two episodes of 
diarrhoea per year in children under five years of age with 500 deaths per year. In 
developing countries, the rate of diarrhoea is two to three times higher. Medical 
costs and loss of productivity due to infectious diarrhoea amounts to US$23 billion 
per year in the United States (SLEISENGER and FORDTRAND, 1993). 
 
Acute bacterial diarrhoea can be classified into two types. Toxigenic type, which 
occur when enterotoxins are the major pathogenic mechanism, while the invasive 
type occurs when the organism penetrates the mucosal surface, however, 
enterotoxins may be produced as well (SLEISENGER and FORDTRAND, 1993).  
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Bacterial gastro-intestinal infections are characterized by loss of appetite, bloating, 
nausea, vomiting, abdominal cramps and pains, bloody stools, pus in the stools, 
and accompanied by fever as well as overall weakness (JULIA, 2006). 
 
Common types of intestinal bacterial infections can be linked to Salmonella 
enteritadis and Campylobacter species. However, Escherichia coli, Listeria 
monocytogenes, Staphylococcus aureus and Bacillus species are creating 
increased concern in developed nations while cholera and shigellosis remain two 
diseases of great concern in developing countries. E. coli is a major cause of 
traveller’s diarrhoea, infantile gastroenteritis and haemorrhagic diarrhoea. The 
bacterium attaches to the intestinal epithelial cells and produces enterotoxins that 
cause acute watery diarrhoea in adults by mechanisms similar to cholera toxin 
(SLEIGH and TIMBURY, 1998).  Klebsiella pneumoniae has also been reported to 
cause food poison which results in diarrhoea (ROBERT et al., 1990). 
Staphylococcus aureus is an important pyogenic organism causing toxic food 
poisoning and superficial infections such as abscesses. Bacillus species (B. 
subtilis, B. pumilus and B. licheniformis) cause food poisoning which results in 
food poisoning, abdominal pains and diarrhoeal diseases. Other gastro-intestinal 
bacteria include Yersinia enterocolitica, Clostridium perfringens, Clostridium 
difficile and Vibrio cholerea. They are associated with symptoms ranging from 
illness, headache, anorexia, lower abdominal pains and lassitude. With the 
increasing rate of mortality among children, the immuno-compromised and old 
people, including HIV patients, as a result of gastro-intestinal bacterial pathogens 
other than commonly identified pathogens should not be ignored (BARBARA, 




3.1.2 Treatment of Gastro-intestinal Bacterial Infections  
 
Bacterial infections are among the few diseases in medicine for which specific 
therapies are available. However, despite this, infections are still common and 
treatment may fail. Bacteria are generally classified as either Gram-positive or 
Gram-negative by testing them with the Gram stain. The stain attaches to part of 
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the bacterial cell wall called peptidoglycan and causes a purple colouration. The 
cell wall of Gram-positive bacteria is a relatively simple structure which forms no 
appreciable barrier to the entry of antibiotics. It contains many layers of 
peptidoglycan which is closely associated with the cytoplasmic membrane. On the 
other hand, the cell wall of Gram-negative bacteria contains an outer membrane 
which is made up of lipopolysaccharides, and the peptidoglycan layer is separated 
from the cytoplasmic membrane by the periplasm. It also contains specific 
proteins, which include pore-forming proteins through which hydrophilic molecules 
are transported. Teichoic acids which help in the maintenance of the level of 
divalent cations outside the cytoplasmic membrane are also found in the cell wall 
of Gram-negative bacteria (SLEIGH and TIMBURY, 1998). 
 
There are various treatments for bacterial infections in the public health system in 
all countries. Patients suffering from diarrhoea as a result of gastro-intestinal 
infections are subjected to fluid and electrolyte replacement to restore lost body 
fluids. Commercially available rehydration fluids which contain glucose and 
electrolytes (0.9% saline) are prescribed to facilitate water absorption in patients 
with watery stools except when losses are very severe or it is associated with 
profound vomiting (BARBARA, 1998; SLEIGH and TIMBURY, 1998). 
Antimicrobial therapy is also used with antibiotics against pathogens for the 
treatment of infectious gastro-intestinal bacterial ailments (MICHAEL and PAUL, 
2007). Antimicrobial drugs are often classified as bactericidal when they kill the 
infecting bacteria or as bacteriostatic when they prevent multiplication but do not 
kill the bacteria.  Some of the common antimicrobial drugs that are used against 
gastro-intestinal pathogens include trimethoprim-sulfamethoxazole, quinolone, 
doxycycline and chloramphenicol. Unfortunately, resistance increasingly limits 
their usefulness. A rapid increase in fluoroquinolone resistance in Salmonella in 
some regions has been extremely worrisome (SLEIGH and TIMBURY, 1998; 
STEPHEN et al., 2003). 
 
South African traditional medicine makes use of a wide variety of plant species to 
treat stomach-related diseases which are prevalent in the rural areas (McGAW et 
al., 2000). Herbal medications often are high in tannins, which act as astringents 
and thereby act to control diarrhoea, and also reduce or prevent the colonization of 
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the infectious agent. According to LEWIS and ELVIN-LEWIS (2003), the 
therapeutic value of a known South African diarrhoea mixture is attributed to 
specific tannins from Areca catechu contained in the mixture. 
 
 
3.1.3     Ethnopharmacological Search for Antimicrobial Plants 
 
Studies based on the ethnobotanical use of plants have often proved to be a more 
efficient method of drug discovery than random plant screening (SLISH et al., 
1999; KHAFAGI and DEWEDAR, 2000). In the past decades, several ethno-
pharmacological studies aimed at evaluating the antimicrobial potentials of 
traditional medicinal plants used as antimicrobials in many countries such as 
South Africa, China and Nigeria have been reported (MENEZES and RAO, 1998; 
MUKHERJEE et al., 1998; TONA et al., 1999; RAHMAN et al., 2003; TANGPU 
and YADAV, 2004).  
 
In South Africa, similar studies on the antimicrobial activities of medicinal plants 
that are used against gastro-intestinal pathogens have been reported. McGAW et 
al. (2000) reported on the antimicrobial activities of some medicinal plants. Among 
the plants evaluated Cassine transvaalensis, Catha edulis, Combretum 
apiculatum, Harpephyllum caffrum, Heteromorpha trifoliate, Schotia brachypetala 
and Sclerocarya birrea showed interesting antibacterial activities with MIC value 
less than 200 µg/ml against some diarrhoea-causing bacteria.  
 
MATHABE et al. (2006) also evaluated the antibacterial activities of medicinal 
plants that are used for the treatment of diarrhoea in Limpopo Province using both 
agar-well diffusion and microdilution methods. Punica granatum and Ozoroa 







3.2  Materials and Methods 
3.2.1  Extract Preparation for Antibacterial Assay 
 
The extraction of different plant materials were carried out as described in 
Sections 2.1.2 and 2.1.3. Dried plant extracts were resuspended to a 
concentration of 50 mg/ml in water for aqueous extracts or 70% ethanol for 
organic solvent extracts on the day of the experiment. 
 
 
3.2.2 Storage and Maintenance of Bacterial Strains 
 
Two Gram–positive (Bacillus subtilis, ATCC 6051 and Staphylococcus aureus, 
ATCC 12600) and two Gram–negative (Escherichia coli, ATCC 11775 and 
Klebsiella pneumoniae, ATCC 13883) bacteria were used. From the bacteria 
stocks kept at -70 ºC, suspension cultures were prepared in 5 ml Mueller-Hilton 
(MH) broth (Oxoid) at 37 ºC overnight in an orbital shaker. After 18 h the 
suspension cultures were streaked on MH sterile media rich agar and then 
incubated overnight at 37 ºC in an incubator. The solid cultures were removed 
from the incubator and kept at 4 ºC in the fridge. This process was repeated every 




3.2.3  The Antibacterial Microdilution Assay 
 
Plant extracts were evaluated for their antibacterial activity using the microdilution 
antibacterial assay by determining minimum inhibitory concentration (MIC) as 
described by ELOFF (1998). Overnight cultures of two Gram-negative bacteria 
((Escherichia coli ATCC 11775 (7.0 x 1010 CFU/ml) and Klebsiella pneumoniae 
ATCC 13883 (2.5 x 109 CFU/ml)) and two Gram-positive bacteria (Bacillus subtilis 
ATCC 6051 (4.8 x 109 CFU/ml) and Staphylococcus aureus ATCC 12600 (2.7 x 
109 cfu/ml)) were diluted with sterile Mueller-Hinton (MH) broth (Oxoid). One 
hundred microlitres of each of the suspended extract were two-fold serially diluted 
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with sterile water in a sterile 96-well micro-plate (Greiner Labortechnik) (one 
microplate per test bacterium) with each extract concentrations ranging from 12.5 
mg/ml to 0.098 mg/ml in the micro-plate wells. A similar two-fold serial dilution of 
neomycin was used as the positive control while 70% ethanol and bacteria-free 
broth were used as the negative controls. The bacterial saturated suspension 
cultures were diluted (1:100) with sterile MH broth, with 100 µl being added to 
each of the wells containing the test and control solutions. The micro-plates were 
covered with parafilm and incubated at 37 ºC for 24 h. The MIC values were 
obtained by adding 50 µl of 0.2 mg/ml p-iodonitrotetrazolium chloride (INT) 
(Sigma) and incubated further at 37 ºC for 2 h. Since the colourless tetrazolium 
salt is biologically reduced to a red product due to the presence of an active 
organism, the MIC values were recorded as the concentrations in the last wells in 
which no colour change was observed after adding the INT indicator. The 
screening was repeated three times in duplicate for each extract to determine an 
average MIC value. 
 
 
 3.3 Results and Discussion 
 
3.3.1  Antibacterial Activity of Plant Extracts 
 
The results of antibacterial minimum inhibitory concentration (MIC) of evaluated 
plant extracts are presented in Table 3.1.  A range of antibacterial activity was 
exhibited by the screened extracts. According to VAN VUUREN (2008), natural 
products with MIC values below 1.0 mg/ml are considered noteworthy. In this 
study, plant crude extracts showing antibacterial activity with MIC values less than 
1.0 mg/ml are considered to have good activity. Some degree of antibacterial 
activity was exhibited by most of the plant extracts with 25 extracts showing good 








Table 3.1: Antibacterial minimum inhibitory concentration of screened extracts 
 Plant  Antibacterial MIC (mg/ml) 
Plant name part Extract E. c K. p B. s S.a 
A.  campanulatus L PE 6.25 1.56 3.125 3.125 
 
 DCM 3.125 3.125 0.39* 1.56 
 
  EtOH 6.25 3.125 4.69 9.38 
 
  Water >12.5 >12.5 >12.5 >12.5 
 
  Boiledª >12.5 >12.5 >12.5 >12.5 
 
 R PE 3.125 3.125 3.125 3.125 
 
  DCM 3.125 3.125 1.56   3.125 
 
  EtOH 3.125 3.125 3.125 3.125 
 
  Water >12.5 >12.5 >12.5 >12.5 
 
  Boiled >12.5 >12.5 >12.5 >12.5 
 
A.  venosum L PE 4.2 5.2 5.2 8.3 
 
  DCM 3.125 4.69 3.52 9.4 
 
  EtOH 3.125 3.125 5.21 0.650 
 
  Water 12.5 12.5 12.5 7.8 
 
  Boiled >12.5 >12.5 >12.5 >12.5 
 
B.  obovatum L PE 0.195 0.195 0.195 0.098 
 
  DCM 1.95 1.95 0.52 2.3 
 
  EtOH 3.125 3.125 0.074 0.195 
 
  Water >12.5 >12.5 >12.5 >12.5 
 
  Boiled >12.5 >12.5 >12.5 >12.5 
 
 R PE 3.91 3.65 3.65 3.91 
 
  DCM 3.125 3.125 1.56 3.125 
 
  EtOH 3.125 3.125 2.343 1.56 
 
  Water >12.5 >12.5 >12.5 >12.5 
 




 Plant Antibacterial MIC (mg/ml) 
Plant name part Extract E. c K. p B. s S.a 
C.  hirsutus L PE 0.098 0.26 0.26 0.13 
  DCM 0.59 2.08 0.78 1.04 
  EtOH 4.69 3.125 1.56 1.56 
 
  Water >12.5 >12.5 >12.5 >12.5 
 
  Boiled >12.5 >12.5 >12.5 >12.5 
 
C.  textilis R PE 4.69 4.69 0.975 4.69 
 
  DCM 3.125 4.69 0.78 1.56 
 
  EtOH 3.125 1.56 0.29 0.195 
 
  Water 12.5 12.5 12.5 12.5 
 
  Boiled >12.5 >12.5 >12.5 >12.5 
 
C.  textilis L PE 4.69 4.69 3.125 3.125 
 
  DCM 3.125 6.25 3.125 3.125 
 
  EtOH 4.69 2.34 0.59 0.15 
 
  Water 12.5 9.38 9.38 12.5 
 
  Boiled >12.5 >12.5 >12.5 >12.5 
 
D. lycioides L PE 3.125 4.69 2.34 3.65 
 
  DCM 4.69 4.69 3.125 3.125 
 
  EtOH 3.125 3.125 1.56 1.3 
 
  Water >12.5 >12.5 >12.5 >12.5 
 
  Boiled >12.5 >12.5 >12.5 >12.5 
 
D. lycioides S PE 6.25 4.69 1.56 3.65 
 
  DCM 6.25 6.25 0.59 0.59 
 
  EtOH 4.69 3.125 2.3 1.3 
 
  Water >12.5 >12.5 >12.5 >12.5 
 
  Boiled >12.5 >12.5 >12.5 >12.5 
 









Extract E. c K. p B. s S.a 
 














  DCM 3.125 6.25 3.125 6.25 
 
  EtOH 1.56 2.08 0.78 0.46 
 
  Water 1.56 0.78 0.78 0.78 
 
















  DCM 1.95 4.69 0.39 0.39 
 
  EtOH 6.25 6.25 6.25 4.29 
 
  Water >12.5 >12.5 >12.5 >12.5 
 
  Boiled >12.5 >12.5 >12.5 >12.5 
 
H.  limifolia L PE 0.52 0.91 0.163 0.098 
 
  DCM 2.6 2.6 1.3 1.56 
 
  EtOH 3.125 3.125 3.125 3.125 
 
  Water >12.5 >12.5 >12.5 >12.5 
 
  Boiled >12.5 >12.5 >12.5 >12.5 
 
P.   simplex L PE 0.098 0.33 0.26 0.195 
 
  DCM 0.32 0.49 0.44 0.59 
 
  EtOH 3.125 1.56 1.56 0.78 
 
  Water >12.5 >12.5 >12.5 >12.5 
 
  Boiled >12.5 >12.5 >12.5 >12.5 
 
P.  simplex B PE 1.56 1.56 1.56 0.19 
 
  DCM 3.125 3.125 1.56 0.78 
 
  EtOH 2.34 3.125 
 
0.29 0.147 
  Water 6.25 12.5 3.125 >12.5 
 



































  EtOH 4.69 3.125 3.125 1.56 
 
  Water 12.5 12.5 12.5 12.5 
 
  Boiled >12.5 >12.5 >12.5 >12.5 
 
W.  tabularis C PE 3.125 3.125 0.15 0.39 
 
  DCM 3.125 3.125 0.59 1.56 
 
  EtOH 4.69 3.125 2.3 1.56 
 
  Water 12.5 12.5 12.5 12.5 
 
  Boiled >12.5 >12.5 >12.5 >12.5 
 
Neomycin   1.58 x10‾3 7.8 x 10‾4 1.47 x10‾4 3.9 x10‾4 
 
E.c; Escherichia coli, K.p; Klebsiella pneumoniae, B.s; Bacillus subtilis, 
S.a; Staphylococcus   aureus, B- bark, C-corm, L-leaf, R-root, S-stem. 
ª Extracts from boiled plant parts; *Extracts with values in bold are considered 
active 
 
Gram-positive B. subtilis was the most susceptible bacterium (Figure 3.1). Twenty 
one extracts showed good activity against the bacterium. Nineteen extracts 
showed good activity against S. aureus, six extracts showed activity against both 
Gram-negative bacteria (K. pneumoniae and E. coli). The observed results agree 
with MARTIN, 1995; SLEIGH and TIMBURY, 1998 that Gram-negative bacteria 
are more resistant than Gram-positive ones as a result of the protective cell 
membrane composition. The same observation has also been reported by other 
authors (VLIETINCK et al., 1995; VALSARA et al., 1997; McGAW et al., 2000; 



















Figure 3.1 Susceptibility of test bacteria to plant extracts (MIC ≤ 1.0 mg/ml). 
 
 
The EtOH extract of Becium obovatum (leaf) showed the best antibacterial activity 
with an MIC value of 0.074 mg/ml against B. subtilis.  Petroleum ether leaf extracts 
of Becium obovatum, Cucumis hirsutus, Haworthia limifolia and Protea simplex 
showed antibacterial activity with MIC values ranging between 0.098 and 0.910 
mg/ml against all the test bacteria. All the organic extracts of Becium obovatum 
(leaf), Protea simplex (leaf and bark), and Cyperus textiles (root) showed 
antibacterial activity with MIC values ranging between 0.098 to 0.975 mg/ml 
against at least one of the test bacteria. Good antibacterial activity was exhibited 
by the some extracts of Becium obovatum leaves but a relatively weak 
antibacterial activity was observed in all the root extracts. Interestingly, the 
traditional healers make use of decoctions prepared from the roots to treat 
diarrhoea and dysentery (HUTCHINGS et al., 1996). The observed antibacterial 
activity showed by leaf extracts of Becium obovatum could be as a result of larger 
amount of active compound present in the plant part. According to STEENKAMP 
et al. (2006), it is equally possible that different compounds could be responsible 



























B. subtilis E. coli K. pneumoniae S. aureus
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exhibited by the organic leaf extracts of Protea simplex (between 0.098 and 3.125 
mg/ml) was better than the antibacterial activity showed by the bark extracts.  It is 
noteworthy that the bark is used traditionally for the treatment of diarrhoea and 
dysentery (WATT and BREYER-BRANDWIJK, 1962). Moreover, better 
antibacterial activity showed by the leaves of Becium obovatum and Protea 
simplex compared to the activity showed by the root and bark supports the idea of 
plant part substitution for sustainable use (ZSCHOCKE and VAN STADEN, 
2000). Cineole, hydrocyanic acid and myristic acid are present in Cyperus species. 
Haworthia species are said to contain anthraquinones, and a medicinal compound 
called cucumin was reported in Cucumis hirsutus (HUTCHINGS et al., 1996). It 
can be hypothesized that some of these compounds may be contributing to the 
antibacterial activity exhibited by the plant extracts. 
 
Agapanthus campanulatus (leaf), Cyperus textiles (leaf and root), Vernonia 
natalensis (leaf), Watsonia tabularis (corm), Antidesma venosum (leaf), Diospyros 
lycioides (stem), and Gladiolus dalenii (corm) exhibited good but selective 
antibacterial activity against at least one of the Gram-positive test bacteria. 
Generally, aqueous extracts showed poor antibacterial activity in most of the plant 
species however the aqueous extract of Dissotis princeps showed exceptional 
activity with an MIC value of 0.78 mg/ml against Gram-positive and Gram-negative 
bacteria. Surprisingly, no bacterial growth inhibition was observed in any of the 
boiled plant extracts at the highest concentration assayed except in Dissotis 
princeps extract with a poor antibacterial activity against the test bacteria.  
According to IEVEN et al. (1979), polyphenols have antimicrobial activities and are 
soluble in water. This could explain the exceptional antibacterial activity exhibited 
by Dissotis princeps aqueous extract. In comparison, there was a significant 
decrease in activity with boiled plant extracts compared with water extracts. This 
evidently suggests that heat could have some destructive effects on the active 
compounds present in the medicinal plants. The positive control (neomycin) 
inhibited all bacterial growth with MIC values ranging between 0.147-1.580 µg/ml. 
Ethanol (70%) used as a negative control showed no bacterial growth inhibition at 
the highest concentration equivalent to the screened plant extracts, this ruled out 




Of all the plants evaluated, leaf extracts of Cucumis hirsutus, Becium obovatum, 
Dissotis princeps, Haworthia limifolia and Protea simplex showed a broad 
spectrum and non-selective antibacterial activity against the test bacteria. These 
plant extracts could be equally active against other resistant bacteria especially 
Gram–negative ones such as Salmonella typhi, Shigella dysenteriae and Vibrio 
cholerae that are responsible for acute gastro-intestinal infections. Further 
investigation aimed at isolating and identifying the compounds responsible for the 
activity against Gram–negative bacteria is necessary.  
 
 
3.4  Conclusions 
 
At least one extract from all the investigated plant species showed antibacterial 
activity with varying MIC values. This suggests the presence of antibacterial 
principles in them. Bacteria account for more than 60% of acute gastro-intestinal 
microbial infections and other related ailments which are prevalent in rural areas 
(BAUMLER et al., 2000; ADAK et al., 2002). Most of the test bacteria in this 
study are reported to be involved in microbial infections such as acute diarrhoea, 
dysentery, abdominal pains and other microbial infections (ROBERT et al., 1990; 
SLEISENGER and FORDTRAND, 1993; BURTON and ENGELKIRK, 1995; 
SLEIGH and TIMBURY, 1998; BRIAN, 1996; NIYOGI et al., 2000; MERCY, 
2005; ADEGUNLOYE, 2006). The results presented in this study validate the use 
of most of these plants as antimicrobials in traditional medicine. Although PE, 
DCM and EtOH extracts were evaluated in this study, PE and DCM are not 
accessible to traditional healers; water is the most commonly used solvent by 
many traditional healers or water-ethanol mixtures in some cases (JEAN, 1990; 
ZSCHOCKE and VAN STADEN, 2000). The activity of aqueous extracts from 
medicinal plants could be said to be dose dependent. Weak antibacterial activity 
observed in aqueous extracts could suggest that most of the active compounds 
present in the evaluated medicinal plants are less polar therefore they are 
extracted in small quantities because of their weak affinity to water. However, 
good antibacterial activity could be achieved at higher concentrations. Practically, 
more cups of tea or decoction prepared from the medicinal plants would be 




EVALUATION OF ANTIFUNGAL ACTIVITY IN 
INVESTIGATED PLANT EXTRACTS 
 
 
4.1 Fungal Gastro-intestinal Infections 
 
Infections due to fungal pathogens have become more frequent with the rise of 
HIV infection (WALSH and GROLL, 1999; FLEMING et al., 2002). Opportunistic 
fungal pathogens have become a common cause of morbidity and mortality 
(GARBINO et al., 2001). In adults, fungal gastroenteritis is encountered in the 
tropics. It is associated with persistent diarrhoea, anorexia, abdominal bloating, 
substantial weight loss and overt steatorrhoea (MICHAEL and PAUL, 2007). 
 
Major intracellular gastro-intestinal fungal pathogens are Microsporidia, Candida 
albicans, Aspergillus, and Cryptococcus. They are the common types that cause 
persistent and severe diarrhoea particularly in the immuno-compromised such as 
HIV-positive patients. People most likely get fungal infections by ingesting 
contaminated foods. These organisms may also contaminate fresh water streams, 
making villagers and campers part of the risk groups of the infection. Pathogenic 
fungi invade the intestinal mucosa in patients while the opportunistic ones become 
pathogenic and virulent when the immune system is compromised (BARBARA, 
1998; LEWIS and ELVIN-LEWIS, 2003). 
 
Candida albicans is an opportunistic pathogen that causes severe inflammatory 
diarrhoea. Mortality associated with systemic C. albicans infections is 
approximately 35 to 50%. In South Africa where many patients are 
immunocompromised as a result of the AIDS pandemic, infections caused by C. 
albicans are common (SHAI  et al., 2008). Isospora belli is a common pathogen 




4.2 Treatment of Fungal Infections 
 
With the limited availability of antifungal drugs and the increasing incidence of 
opportunistic fungal infections, the emergence of drug resistant fungal pathogens 
poses a serious public health concern. Antifungal drug resistance has been 
studied most extensively with the yeast Candida albicans because it is an 
opportunistic pathogen (COWEN et al., 2002). 
 
There has been extensive research into the development of antifungal drugs. 
Some of the widely used antifungal drugs for the treatment of fungal infections 
include Amphotericin B, azoles, imiazoles, miconazole and ketoconazole, triazole 
and itraconazole as well as pyrimidine inhibitors (PFALLER et al., 1996). In 
traditional medicine, a lot of medicinal plants are used to treat Candida infections. 
Many researchers have investigated numerous medicinal plants for anti-candidal 
potentials (CLARK and HUFFORD, 1993). A few antifungal compounds have 
been isolated from medicinal plants species. Medicinal plant antifungal activity has 
been associated with plant secondary metabolites such as phenols, glycosides, 
lactones and saponins (AGARWAL et al., 2000). 
 
 
4.3 Materials and Methods 
 
4.3.1  Extract Preparation for Antifungal Assay 
 
Plant extracts were prepared as described in Sections 2.1.2 and 2.13. Dried plant 
extracts were resuspended to a concentration of 50 mg/ml in water for aqueous 
extracts or in ethanol (70%) for organic solvent extracts for antifungal evaluation 






4.3.2 Storage and Maintenance of Fungal Strain 
Candida albicans (ATCC 10231) obtained from the South African Bureau of 
Standards was used in the assay. From the Candida albicans stock kept at -70 ºC, 
suspension culture was incubated overnight in 5 ml Yeast Malt (YM) broth at 37 °C 
on an orbital shaker. The overnight culture was streaked on Yeast Malt (YM) broth 
rich sterile media agar in a Petri-dish. The agar culture was incubated at 37 °C in 
an incubator. After 18 h the agar culture was removed and kept at 4 °C in the 
fridge. This process was repeated every 30 days in order to maintain the potency 
of the fungus (WISTREICH, 1997; THIEL, 1999). 
 
 
4.3.3  The Antifungal Microdilution Assay 
 
A microdilution method as described by MASOKO et al. (2007) was used to 
determine the antifungal activity. An overnight fungal culture was prepared in 5 ml 
Yeast Malt (YM) broth. Sterile saline (0.85% NaCl) was added to the fungal culture 
such that the absorbance of the fungal culture at 530 nm was in the range of 1 ml 
of a 0.5 M McFarland standard solution (which is between 0.2500 and 0.2800). 
The standardised fungal culture was further diluted with sterile YM broth (1:1000) 
(approximate 5 x l05 CFU/ml). One hundred microlitres of each resuspended 
extracts were two-fold serially diluted with sterile water in a 96-well micro-plate 
(Greiner Labortechnik) with each extract concentrations ranging from 12.5 mg/ml 
to 0.0123 mg/ml in the wells. A similar two-fold dilution of solution of Amphotericin 
B was prepared as the positive control while ethanol (70%) and fungal-free wells 
were used as the negative controls.  One hundred microlitres of the dilute Candida 
culture were added to each well. The plates were covered with parafilm and 
incubated at 30 °C for 48 h. The MIC values were obtained by adding 50 µl of (0.2 
mg/ml) p-iodonitrotetrazolium (INT) (Sigma, Steinham, Germany) and then 
incubating for another 2 h.  Fungicidal activity of the plant extracts was determined 
by adding 50 µl YM broth to all the wells with no colour change and further 
incubated at 37°C for 24 h. Candida growth in the wells was indicated by a 
reddish-pink colour, whereas clear wells indicated growth inhibition by plant 
extracts. The concentrations of extracts in the last clear wells were taken as the 
37 
 
minimum fungicidal concentration (MFC). The screening was done in triplicate and 
repeated twice for each extract, the average MIC and MFC values are reported. 
 
 
4.4 Results and Discussion 
 
4.4.1  Antifungal Activity of Plant Extracts 
 
According to SLEIGH and TIMBURY (1998) C. albicans is resistant to all 
antibacterial antibiotics. The results obtained evidently showed that C. albicans is 
resistant to most of the plant extracts. Only six plant extracts showed interesting 
antifungal activity with MIC values less than 1.0 mg/ml. BUWA and VAN STADEN 
































Table 4.1: Antifungal activity (MIC and MFC) of investigated plant extracts used 
  traditionally against C. albicans 
Antifungal concentration (mg/ml) 
Plant species Plant part Extracts MIC MFC 
     
A. campanulatus L PE  9.38 12.5 
  DCM  3.125 6.25 
  EtOH  0.29* 0.29 
  Water  > 12.5 > 12.5 
  Boiledª > 12.5 >12.5 
     
 R PE  6.25 6.25 
  DCM  4.69 6.25 
  EtOH  0.39 0.39 
  Water  > 12.5 > 12.5 
  Boiled > 12.5 >12.5 
 
A. venosum L PE 3.125 4.69 
  DCM  3.125 4.69 
  EtOH  3.125 6.25 
  Water  > 12.5 > 12.5 
  Boiled > 12.5 >12.5 
 
B. obovatum R PE 4.69 6.25 
  DCM  3.125 3.125 
  EtOH  4.17 6.25 
  Water  > 12.5 > 12.5 
  Boiled > 12.5 >12.5 
 
C. hirsutus L PE 6.25 6.25 
  DCM  4.69 4.69 
  EtOH  3.125 4.17 
  Water  > 12.5 > 12.5 
  Boiled > 12.5 >12.5 
 
C. textilis R PE 6.25 6.25 
  DCM  4.69 6.25 
  EtOH  3.125 3.125 
  Water  > 12.5 > 12.5 
  Boiled > 12.5 >12.5 
 
 L PE 6.25 9.38 
  DCM  1.17 1.56 
  EtOH  3.125 5.21 
  Water  > 12.5 > 12.5 








                         Antifungal concentration (mg/ml) 
Plant species Plant part Extract MIC MFC 
D. lycioides L PE 3.125 3.125 
  DCM  3.125 4.69 
  EtOH  4.17 8.33 
  Water  > 12.5 > 12.5 
  Boiled > 12.5 >12.5 
  
 S PE 6.25 6.25 
  DCM  3.125 3.125 
  EtOH  4.17 8.33 
  Water  > 12.5 > 12.5 
  Boiled > 12.5 >12.5 
 
D.  princeps L PE 1.56 1.56 
  DCM  6.25 6.25 
  EtOH  0.014 0.037 
  Water  > 12.5 > 12.5 
  Boiled > 12.5 >12.5 
 
G. dalenii C PE 6.25 6.25 
  DCM  3.125 3.125 
  EtOH  0.39 0.39 
  Water  > 12.5 > 12.5 
  Boiled > 12.5 >12.5 
 
H. limifolia L PE 6.25 6.25 
  DCM  4.69 6.25 
  EtOH  6.25 6.25 
  Water  > 12.5 > 12.5 
  Boiled > 12.5 >12.5 
 
P. simplex L PE 0.014 0.014 
  DCM  0.39 0.39 
  EtOH  3.125 3.125 
  Water  > 12.5 > 12.5 
  Boiled > 12.5 >12.5 
 
 B PE 12.5 12.5 
  DCM  9.38 12.5 
  EtOH  3.125 12.5 
  Water  > 12.5 > 12.5 
  Boiled > 12.5 >12.5 
 
V. natalensis L PE 5.21 6.25 
  DCM  3.125 4.69 
  EtOH  3.125 5.21 
  Water  > 12.5 > 12.5 















ª Extracts from boiled plants; * Extracts with values in bold are considered active 
MIC - minimum inhibitory concentration; MFC - minimum fungicidal concentration 
B- bark, C-corm, L-leaf, R-root, S-stem. 
 
The best fungicidal activity was shown by the petroleum ether extract of Protea 
simplex leaf with MIC and MFC value of 0.014 mg/ml, the same fungistatic activity 
was also exhibited by the EtOH extract of Dissotis princeps leaf. The EtOH leaf 
and root extracts of Agapanthus campanulatus exhibited good fungicidal activity 
with MFC values of 0.29 and 0.39 mg/ml respectively. Interesting MFC value was 
also exhibited by EtOH extracts of Gladiolus dalenii. Similarly, good fungicidal 
activity was shown by the DCM leaf extracts of Protea simplex (0.39 mg/ml) and 
the EtOH leaf extract of Dissotis princeps (0.037 mg/ml). Amphotericin B exhibited 
antifungal activity with MIC and MFC values of 6.9 and 13 µg/ml respectively. 
 
The antifungal activity exhibited by Protea simplex leaf PE extracts is impressive 
considering the low concentration at which the Candida growth was inhibited. This 
suggests that the activity may reside in the lipophilic leaf compounds extracted in 
PE. A comparable difference in the antifungal activity exhibited by Protea simplex 
leaves and bark could be attributed to the types of active compounds in the plant 
parts. Several saponins and sapogenins of the furistane and spirostane types that 
have a large number of biological activities and biochemical effects have been 
isolated from the roots of Agapanthus species (VAN WYK et al., 1997). The 
antifungal activity exhibited by Agapanthus campanulatus leaf and root EtOH 
extracts could in part be attributed to the reported compounds. No visible 
antifungal activity was observed in all the water and boiled extracts at the highest 
concentration assayed. However, negative results do not mean that the plant 
extracts are inactive or absence of bioactive compounds. Active compounds may 
W. tabularis C PE 4.69 6.25 
  DCM  4.69 7.81 
  EtOH  3.125 6.25 
  Water  > 12.5 > 12.5 
  Boiled > 12.5 >12.5 
 
Amphotericin  B    6.9 x10-3 1.3 x 10-2 
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be present in insufficient quantities in the crude aqueous extracts for them to show 
activity with the concentrations assayed, therefore lack of activity can be proven by 





Plant species that showed good fungistatic and or fungicidal activity at a 
concentration less than 1.0 mg/ml are Protea simplex, Dissotis princeps, 
Agapanthus campanulatus and Gladiolus dalenii. C. albicans is a morphologically 
changing organism; therefore it has the ability to develop resistance against many 
antifungal compounds. It will be interesting to investigate the compound or group 
of compounds that are responsible for this activity as they could be more active 




























5.1 Introduction  
 
Mutagenesis is a health problem because the mechanism may lead to different 
types of cancer which are increasing at an alarming rate in humans. Mutagenic 
mechanisms involve anything that damages the DNA or interferes with the 
structure of the DNA, or with cell division. A given mutagen interacting with the cell 
may induce different types of genetic lesions, ranging from a single-based 
modification, which might completely be restored in its initial form, or results in the 
loss of a chromosome. These different types of mutations occur in somatic cells 
and might lead to cancer or alterations on seminal cells giving rise to congenital 
diseases, degenerative disorders, aging, and genetic defects in the offspring. 
However, often, human cells are able to protect themselves against defective 
replications through DNA repair processes (KIRSCH-VOLDERS, 1984; 
CUZZOCREA et al., 2001; MIGLIORE and COPPEDỀ, 2002).  
 
Plants in general, synthesize toxic substances, which in nature act as a defence 
against infections, insects and herbivores; however, they also can affect man 
(CUZZOLIN et al., 2006). Based on the long-term use of medicinal plants by 
humans, an assessment of their mutagenic and cytotoxic potential is necessary to 
ensure a relatively safe use of plant-derived medicines. The genotoxic effects of 
widely used plants are not well documented in the literature. However, recent 
investigations have revealed that some plants used as food or in traditional 
medicine have mutagenic effects in in vitro assays (HIGASHIMOTO et al., 1993; 
SCHIMMER et al., 1994; KASSIE et al., 1996; ELGORASHI et al., 2003). 
Extracts of Crinum macowanni, Ziziphus mucronata, Chaetacme aristata, 
Plumbago auriculata, Catharanthus roseus, Diospyros whyteana and Combretum 
mkhzense have been reported to be mutagenic for strain TA98 of Salmonella 
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typhimurium (ELGORASHI et al., 2003). Mutagenic plant compounds can 
themselves be intrinsically mutagenic, or can become mutagenic after activation 
and transformation by enzymatic and metabolic processes. This raises concern 
about the potential mutagenic hazards resulting from the long-term use of such 
plants in humans. 
 
 
5.2 Tests for Genotoxicity 
 
Many in vivo and in vitro tests have been developed to give accurate results of 
genotoxic effects of natural products. The two principal systems used in bacteria 
are the Rec-assay in Bacillus substilus and the reversion assay in Salmonella 
typhimurium. Positive results in the Rec-assay usually indicate a covalent binding 
to DNA or a chemical breakage of DNA while the reversion assay detects frame-
shift mutations and base-pair substitutions and often parallels the carcinogenic 
potential of a compound (MARON and AMES, 1983; KIRSCH-VOLDERS, 1984). 
 
A few tests in yeast and mammalian cells also aim to detect gene mutation, but 
the great majority of tests in eukaryotes assess the capability to induce structural 
or numerical chromosome aberrations with no proof of an induction of gene 
mutations and carcinogenic properties of a compound (KIRSCH-VOLDERS, 
1984). The alkaline comet and micronucleus assays for the screening of potential 
genotoxic compounds utilize a variety of cell types. The alkaline comet assay 
detects primary single- and double-strand breaks and alkali-labile sites before and 
after DNA repair process, while the micronucleus test detects DNA lesions after 
their fixation as chromosome mutations (SINGH et al., 1988). 
 
 
5.3  The Ames Test 
 
The Ames test procedure is described in a series of papers from early 1970s by 
Bruce Ames and his group at the University of California. The Ames test is a 
biological assay widely used for detecting carcinogens and mutagens with 
Salmonella. As cancer is often linked to DNA damage, the test also serves as a 
quick assay to estimate the carcinogenic potential of a compound since the 
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standard tests for carcinogenicity done on rodents take years to complete. The 
test has been used to determine the mutagenicity of complex environmental and 
biological mixtures. The Ames test using Salmonella was first validated in a study 
of 300 chemicals most of which were known carcinogens (McCANN et al., 1975). 
A considerable number of mutagens first detected by the Ames test have been 
shown subsequently to be carcinogenic in other in vivo tests. A set of strains that 
require histidine for growth is used for mutagenicity testing, with each tester strain 
containing a different type of mutation in the histidine operon (MARON and 
AMES, 1983). The standard tester strains used in Ames test include TA 97, TA98, 
TA100, and TA 102. These strains contain the R-factor plasmid (pKM101) which 
carries the hisG428 mutation and a tetracycline resistance gene. In Salmonella, 
pKM101 increases chemical and spontaneous mutagenesis by enhancing an 
error-prone DNA repair system which is normally present in the organism. The 
strain TA98 detects various frame-shift mutagens; the mutagens can stabilize the 
shifted pairing that often occurs in repetitive sequences of the DNA resulting in a 
frame-shift mutation which restores the correct reading frame for histidine 
synthesis. In some cases, rat liver homogenates are added to stimulate the effect 
of metabolism, as some compounds, like benzopyrene are not mutagenic 
themselves but their metabolic products are found to be mutagenic (AMES et al., 
1973; MARON and AMES, 1983).  
 
 
5.4  Materials and Methods 
 
5.4.1  Preparation of Plant Extracts 
 
Plant materials were extracted as described in Sections 2.1.2 and 2.1.3. 
Biologically active extracts were dissolved in 10% DMSO to make a concentration 
of 5 mg/ml and filtered through 0.22 µm filter tips to remove impurities. Three 
concentrations of 50 µg/ml, 500 µg/ml, and 5000 µg/ml were made from each of 






5.4.2  Genotoxicity Testing of Active Plant Extracts 
 
Bioactivity-guided genotoxicity study was employed to test for genotoxicity in crude 
extracts that showed good antimicrobial activities with a minimum inhibitory 
concentration of ≤ 1.0 mg/ml in the antibacterial and antifungal assays reported in 
Chapters 3 and 4. Genotoxic compounds are known to be dose dependent and 
active in living cells. Considering the antimicrobial activities the extracts exhibited 
against living microbial cells, one can suggest that the activity could probably be 
due to the presence (or larger amounts) of biologically active compounds in the 
various active extracts. The Ames assay was performed using the plate 
incorporation procedure with Salmonella typhimurium strain TA98 as described by 
MARON and AMES (1983). Ten millilitres of Oxoid nutrient broth No.2 were 
inoculated with 100 µl stock bacterium (kept at -70 ºC) at 37 ºC for 16 h on an 
orbital shaker. Hundred microlitres of each extract concentration were dispensed 
in culture tubes, followed by adding 500 µl of phosphate buffer. The bacterial 
culture (100 µl) was then added to all the test tubes containing the mixture of plant 
extract and phosphate buffer, after which 2 ml of agar containing traces of biotin 
and histidine were added. Sterile water (100 µl) was used as a negative control 
while 2 µg/ml of 4-Nitroquinoline-N-oxide (4-NQO) which is a known mutagen 
served as a positive control. The mixture was vigorously mixed using a vortex 
mixer (Chiltern), poured over minimal agar plates and allowed to set before being 
inverted and incubated at 37 ºC for 48 h. The positive control and plant extracts 
were tested in triplicate for each concentration, while the negative control was 
tested in five replicas. According to MARON and AMES (1983), for a substance to 
be considered mutagenic in the Ames test, the number of revertant colonies (His+) 
on the plates containing the test compounds must be more than twice the number 
of colonies produced on the negative control plates. After incubation, the number 
of revertant colonies was counted using a colony counter. Cytotoxicity effects of 
the plant extracts on S. typhimurium was determined by comparing the 





5.5  Results and Discussion 
 
5.5.1 Genotoxicity in Plant Extracts  
 
The Ames test using S. typhimurium strain (TA98) detects frame-shift mutations 
based on the spontaneous reversion of S. typhimurium strain from His- to His+ 
caused by crude plant extracts. The bacterium (His+) can then be able to synthesis 
histidine for proper growth. Although no positive results were detected in any of 
the plant extracts, the mean numbers of revertant colonies produced are reported 
in Table 5.1 for reference purposes. 
 
Quercetin, furoquinoline alkaloids and isothiocyanates are among the possible 
mutagens of plant origin (SCHIMMER et al., 1994; KASSIE et al., 1996). There 
are no reports on mutagenic compounds from any of the investigated plant 
species. None of the number of revertant colonies counted was twice the colonies 
in the negative control. This suggests that the plant extracts have no mutagenic 
potential in the Ames test. Most mutagens are also toxic and are dose dependent 
to some extent (MARON and AMES, 1983). Dense background of the agar plates 
after 48 h as compared with the negative control showed that all the plant extracts 
are not toxic to S. typhimurium strain. The absence of genotoxicity in any of the 
screened plant extracts against S. typhimurium bacterial strain is a positive step 
forward in determining the safety of long-term consumption of the plants in 
traditional medicine. Inversely, some genotoxicity is exhibited in the presence of 
metabolic and enzymatic activation. The plant species are administered orally for 
the treatment of gastro-intestinal ailments and may therefore be subjected to 
metabolic and enzymatic activation within the human body. However, further 
investigation of the plant extracts in other genotoxicity tests that make use of 
human white blood cells need to be carried out to confirm the results observed in 








Table 5.1: Number of His+ colonies in S. typhimurium strain TA98 produced by 
  antimicrobial crude plant extracts used in traditional medicine  







Extract concentration (µg/ml) 








29.5 ± 7.5 
 
29.0 ± 6.0 
 
45.5 ± 0.5 
  EtOH 37.0 ± 2.5 25.3 ± 3.7 23.0 ± 4.6 
 
 R DCM 31.0 ± 1.2 28.5 ± 1.5    41.0 ± 1.0 
  EtOH 24.3 ± 1.2 27.3 ± 3.8 43.5 ± 3.5 
 
A. venosum L EtOH 19.7 ± 2.9 22.7 ± 4.3 15.7 ± 1.3 
      
B. obovatum L PE 27.3 ± 4.1 25.1 ± 3.0 23.0 ± 4.3 
  DCM 25.3 ± 2.3 22.3 ± 1.2 24.3 ± 2.2 
  EtOH 26.3 ± 3.3 24.3 ± 1.5 29.3 ± 2.0 
 
C. hirsutus L PE 13.0 ± 1.5 13.3 ± 0.9 15.7 ± 1.5 
  DCM 14.0 ± 1.7 14.0 ± 0.6 17.3 ± 2.6 
 
C. textilis R PE 25.7 ± 3.8 30.0 ± 0.6 27.7 ± 3.3 
  DCM 16.3 ± 2.2 31.3 ± 1.9 26.7 ± 1.5 
  EtOH 17.3 ± 0.7 19.0 ± 3.2 26.7 ± 8.2 
 
D. lycioides S DCM 16.3 ± 0.9 27.3 ± 4.2 25.3 ± 2.4 
 
D.  princeps L EtOH 22.3 ± 3.8 26.3 ± 2.6 32.3 ± 1.2 
 
G. dalenii C DCM 23.0 ± 1.0 22.0 ± 1.0 25.3 ± 4.4 
  EtOH 24.0 ± 2.7 38.0 ± 8.4 27.7 ± 2.9 
 
H. limifolia L PE 14.3 ± 1.7 14.7 ± 0.9 18.7 ± 2.2 
 
P. simplex L PE 18.7 ± 3.2 18.7 ± 2.6 16.3 ± 1.5 
  DCM 20.7 ± 0.9 19.0 ± 1.0 17.3 ± 2.3 
  EtOH 21.3 ± 2.4 25.5 ± 5.5 17.0 ± 1.0 
 
 B PE 20.0 ± 2.0 15.5 ± 0.5 24.0 ± 5.0 
  DCM 17.7 ± 0.7 23.7 ± 2.3 30.5 ± 1.5 
  EtOH 18.0 ± 6.0 18.3 ± 4.7 22.0 ± 3.5 
      
V. natalensis L DCM 21.0 ± 2.0 23.5 ± 0.5 21.3 ± 4.9 
 
W. tabularis C PE 20.3  ± 2.9 33.0  ± 1.5 26.0 ± 2.6 
  DCM 20.0  ± 4.0 22.3 ± 0.7 19.3 ± 1.7 
Negative control revertant colony number =26.0 ± 0.6  
Positive control (4-NQO) (2 µg/ml) revertant colony number = 130.3 ± 17.0 
B- bark; C-corm; L-leaf; R-root; S-stem. 
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5.6  Conclusions 
 
It is interesting that screened plant extracts that exhibited good antimicrobial 
activities showed negative genotoxicity results in the Ames test. The negative 
result observed suggests that isolated compounds from the plant species could be 
potentially non-genotoxic, hence preferable in the preparation of safe antimicrobial 
drugs. Therefore, further pharmacological investigation in the isolation and 
identification of active principles that are responsible for the observed antimicrobial 
activities is relevant and worthy. However, it will be important to subject any 
isolated compounds from the plant species to human based genotoxicity tests to 























EVALUATION OF ANTI-INFLAMMATORY ACTIVITY IN 





 NAIK and SHETH (1976) defined inflammation as a complex, vascular lymphatic 
and local tissue reaction elicited in mammals by the presence of viable and non-
viable irritants. Gastro-intestinal infections involve the inflammation of the gastro-
intestinal tracts and result in intense abdominal pains and cramps of varying 
degrees (BARBARA, 1998). The intestine is vulnerable to muscle spasm in 
patients suffering from gastro-intestinal infections, and most patients suffering from 
such conditions often complain of abdominal cramps and pains. Some types of 
chronic inflammations are caused by self replicating parasite like bacteria, viruses 
or other pathogens. Escherichia coli and other gastro-intestinal pathogens that are 
associated with food poison produce enterotoxins that induce watery diarrhoea 
and abdominal tissue damage through plasmid-encoded invasion factors that 
permit invasion of the mucosa thereby resulting to abdominal pains and chronic 
cramps (NAIK and SHETH, 1976; SLEISENGER and FORDTRAND, 1993).  
 
Inflammation is broadly classified into two categories; acute and chronic 
inflammations. Acute inflammation occurs when a tissue injury is caused by a 
single event such as mechanical trauma, a thermal or chemical burn. It is 
characterized by the exudation of plasma proteins, and the migration of leukocytes 
into the injured area. The chronic inflammation is of a more prolonged duration 
and it is manifested by the presence of lymphocytes and macrophages, resulting 
in fibrosis and tissue necrosis. Persistent chronic inflammation increases the 
development of the degenerative diseases such as rheumatoid arthritis, heart 
diseases, asthma, cancer, acquired immunodeficiency disorder, infections 
(bacteria, fungi, viruses and parasites) and inflammatory bowel disease 
(IWALEWA et al., 2007). There is growing interest in anti-inflammatory activity of 
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plant extracts by pharmaceutical companies as well as the herbal industry. In the 
last few years, a number of anti-inflammatory compounds have been introduced in 
order to find potent and safe anti-inflammatory drugs which would be as effective 
as steroids but without any deleterious effects. Therefore, it is worth evaluating 
medicinal plants that are used traditionally in the treatment of pain related 




6.1.1      Inflammatory Process 
 
The inflammatory response is a complex process triggered by several factors 
ranging from bacterial infection and chemical injury to environmental pollution that 
result in cell injury or death. The inflammatory process is characterised by the 
activation of monocytes, granulocytes and lymphocytes, as well as the release and 
activation of inflammatory mediators, and humoral mediators (SHEK and 
SHEPHARD, 1998). These substances bind to specific target receptors on the 
cells and may increase vascular permeability, promote neutrophil-chemotaxis, 
stimulate smooth muscle contraction, increase direct enzymatic activity, induce 
pain and mediate oxidative damage (COLEMAN, 2002). The inflammatory 
process mediators are termed pro-inflammatory fundamental factors, and they 
result in inflammations of different severity depending on the duration of the injury. 
The overall inflammatory process involves kinins and kinin-generating protease, 
chemoattractant chemokines, pro- and anti-inflammatory cytokines, cell surface 
proteins involved in cell-cell interactions, small bioactive molecules (such as 
platelet activating factor, eicosanoids and histamine), cell surface receptors for the 
foregoing and downstream signal transduction components (POLYA, 2003). 
Cyclooxygenase (COX) is a bi-functional enzyme that first catalyses the addition of 
two molecules of oxygen to arachidonic acid to form the hydroperoxide 
prostaglandin G2 (PGG2), then reduces the hydroperoxide by a peroxidase activity 
(SMITH and SONG, 2002). Cyclooxygenase enzymes exist in two isoforms (COX-
1 and COX-2), coded by distinct genes on different chromosomes. The two 
enzymes show about 50% homology and have similar catalytic activity, but are 
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physiologically distinct. COX-1 is generally constitutive; it has “housekeeping” 
functions (regulation of normal cell activity) including gastric cytoprotection and 
platelet aggregation. In contrast, COX-2 can also be constitutive in some tissues 
but its expression and activity is largely responsive to adverse stimuli (PASINETTI, 
2001; CRONSTEIN, 2002). 
 
In summary, the inflammatory process begins with a stimulus that causes the 
release of prostaglandins from cells. Stimuli such as lipopolysaccharides can 
induce an enzyme responsible for the production of nitric oxide (inducible nitric 
oxide synthase) and the COX enzymes. COX-2 acts by producing prostaglandins, 
particularly prostaglandin E2 (PGE2). In turn, PGE2 acts inside the cell to produce 
various types and quantities of cytokines, which are pro-inflammatory agents that 




6.1.2     Anti-Inflammatory Agents   
 
Anti-inflammatory medications are used to manage pain and inflammatory 
disorders. Anti-inflammatory drugs relieve inflammation and the associated pain by 
blocking specific enzymes that the body needs in order to make prostaglandins as 
inflammation cannot develop without prostaglandins. Drugs which are used as 
anti-inflammatory agents are categorised into two groups namely the non-steroidal 
and the glucocorticoid drugs.  Most anti-inflammatory agents such as aspirin, 
ibuprofen, indomethacin, and COX-2 specific drugs are non-steroidal drugs that 
inhibit prostaglandin synthesis (RANG and DALE, 1987). 
 
Non-steroidal corticosteroid such as cortisol causes inhibition of the arachidonic 
acid, cascade inhibits the synthesis of pro-inflammatory proteins such as inducible 
nitric acid oxide synthase (iNOS) and of pro-inflammatory cytokines as well as the 
immune responses. As a result of the inhibition of COX-1, adverse effects on the 
gastro-intestinal mucosa may arise resulting in gastric ulceration and increase 
cardiovascular problems. A newer class of non-steroidal anti-inflammatory drug 
(NSAID) which includes the brand name Celebrex works by stopping the chemical 
reaction that leads to inflammation in the body, but unlike other NSAIDs, it does 
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not harm the production of chemicals that protect the stomach lining 
(CRONSTEIN, 2002). 
 
A variety of plant-derived compounds are used as anti-inflammatories by inhibiting 
the formation of pro-inflammatory signalling molecules such as prostaglandin or 
leukotrienes. Some plant substances are reported to inhibit the nuclear 
transcriptase factor (NFkB)-mediated signalling pathway in immune cells that 
leads to the production of iNOS, pro-inflammatory cytokines and inducible 
cyclooxygenase (POLYA, 2003).  In some medicinal plants, bioactive flavones 
namely, apigenin, luteolin, and matricine have been identified to be responsible for 
the anti-inflammatory activities by inhibiting cytokine-induced gene expression 
(HERTOG et al., 1993; MERFORT et al.,1994; SAFAYHI et al., 1994). Zingiber 
officinale is a common anti-inflammatory in traditional medicine.  The main 
ingredients (6-gingerol, 6- paradol, 8-paradol and 8-shogaol) identified in the plant 
are reported to have an inhibitory effect on the COX-2 enzyme system as well as 
antitumor and anti-proliferative properties against tumour cells (TJENDRAPUTRA 
et al., 2001). Numerous herbs possess anti-inflammatory effects by inhibiting 
COX-2 enzyme or the activation of transcription factors. Other plant species 
reported to have anti-inflammatory properties include Hamamelis virginiana, 
Echinacea species, Ananas comosus, Arnica montana, Salix alba, Glycyrrhiza 
glabra and Cucuma longa (KROES et al., 1997; RININGER et al., 2000; SURH et 
al., 2001; HUGHES-FORMELLA et al., 2002; SPERONI et al., 2002; BALTINA, 
2003; MERFORT, 2003). 
 
 
6.2  Materials and Methods 
 
6.2.1  Extract Preparation 
 
The extraction of different plant parts was carried out as described in Sections 
2.1.2 and 2.1.3. For each plant sample, dried crude extracts were dissolved in 





6.2.2  Testing COX-1 Inhibition 
 
The COX-1 assay was conducted using the method as described by ELDEEN and 
VAN STADEN (2008). A stock solution of COX-1 enzyme (60 µl) (Sigma-Aldrich) 
stored at -70°C was activated with 1250 µl of co-factor solution (0.3 mg/ml 
Epinephrine, 0.3 mg/ml reduced glutathione in 10 ml of Tris buffer pH 8.0, and 100 
µl hematin solution) (Sigma) and pre-incubated on ice for 5 min. Plant extracts 
were first screened at 10 mg/ml of crude extracts. In duplicate, plant extract (2.5 
µl) were added to 17.5 µl distilled filtered water in Eppendorf tubes (for water 
extracts only 20 µl of the extract was added) to give a final concentration of 250 
µg/ml of organic extract per test solution (2 mg/ml for water extracts per test 
solution). A similar preparation of 5 µM indomethacin (Sigma) was used as a 
positive control. Solvent blank and background (2.5 µl ethanol + 17.5 µl of water) 
were used as negative controls. The enzyme solution (60 µl) was added to the test 
solution and pre-incubated at room temperature for 5 min. The reaction was 
started by adding 20 µl of 14C-arachidonic acid (Amersham) to the test solutions, 
with the enzymes in the background being inactivated by adding 10 µl 2N 
hydrochloric acid (HCl) before incubating the test solution at 37 ºC for 10 min.  The 
incubation was stopped and the reaction terminated by adding 10 µl 2N HCl to 
each test solution. Unlabeled prostaglandins (4 µl of 0.2 mg/ml) (Sigma) which is a 
carrier solution were then added to each test solution. The samples were loaded 
onto individual Pasteur pipettes packed with silica gel (particle size 0.063-0.200 
mm, Merck) with 1 ml of hexane:1,4-dioxan:acetic acid (70:30:0.2 v/v/v) to 
separate prostaglandins from the unmetabolized arachidonic acid. Column 
chromatography was used to elute the unmetabolized arachidonic acid with 4 ml of 
hexane:1,4-dioxan:acetic acid (1 ml at a time) while the elution and collection of 
prostaglandin products was done with 3 ml of ethyl acetate:methanol (85:15 v/v) 
into scintillation vials. Four ml of scintillation fluid was added to the eluate in the 
scintillation vials and the radioactivity was measured using a Beckman L S 6000LL 
scintillation counter. Percentage inhibition of the screened extracts was calculated 
using: 
COX Inhibition (%) =  
 
DPM =Disintegrations per minute. 
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6.2.3  Testing COX-2 Inhibition 
 
The same experimental protocol as for COX-1 was followed but with a different 
type of COX enzyme and the amount of cofactor used in activating the enzyme 
(ELDEEN and VAN STADEN, 2008). Prepared stock solution of COX-2 enzyme 
(60 µl) (Cayman Chemicals) at -70 ºC was activated with 1250 µl of co-factor 
solution (0.3 mg/ml Epinephrine, 0.6 mg/ml reduced glutathione in 10 ml Tris 
buffer pH 8.0, and 100 µl hematin solution) (Sigma-Aldrich) and pre-incubated on 
ice for 5 min. Plant extracts were first screened at 10 mg/ml of crude extracts. In 
duplicate, plant extract (2.5 µl) were added to 17.5 µl distilled filtered water in 
Eppendorf tubes (for water extracts only 20 µl of the extract was added) to give a 
final concentration of 250 µg/ml of each organic extract per test solution (2 mg/ml 
for water extracts per test solution). A similar preparation of 200 µM indomethacin 
(Sigma) was used as a positive control. Solvent blank and background (2.5 µl 
ethanol + 17.5 µl of water) were used as negative controls. The enzyme solution 
(60 µl) was added to the test solution and pre-incubated at room temperature for 5 
min. The reaction was started by adding 20 µl of 14C-arachidonic acid (Amersham) 
to the test solutions. The enzyme in the background was inactivated by adding 10 
µl 2N hydrochloric acid (HCl) before incubating the test solution at 37 ºC for 10 
min.  The incubation was stopped and the reaction terminated by adding 10 µl 2N 
HCl to each test solution. Unlabeled prostaglandins (4 µl of 0.2 mg/ml) (Sigma) 
which is a carrier solution were added to each test solution. The samples were 
loaded onto individual Pasteur pipettes packed with silica gel (particle size 0.063-
0.200 mm, Merck) with 1 ml of hexane:1,4-dioxan:acetic acid (70:30:0.2 v/v/v) to 
separate prostaglandins from the unmetabolized arachidonic acid. Column 
chromatography was used to elute the unmetabolized arachidonic acid with 4 ml of 
hexane:1,4-dioxan:acetic acid (1 ml at a time) while the elution and collection of 
prostaglandin products was done with 3 ml of ethyl acetate:methanol (85:15 v/v) 
into scintillation vials. Four ml of scintillation fluid was added to the eluate in the 
scintillation vials and the radioactivity was measured using a Beckman L S 6000LL 
scintillation counter. COX-2 inhibition was determined as described for the COX-1 
assay. Plant extracts showing COX-2 inhibition greater than 50% were tested at 
lower concentrations (125 and 62.5 µg/ml) for COX-1 and -2 to determine if they 
are dose dependent. Plant extracts were tested in duplicate and repeated twice. 
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6.3 Results and Discussion 
 
6.3.1  COX Inhibition by Investigated Plant Extracts 
 
Inhibitory activities of COX-1 and COX-2 enzymes by plant extracts were reported 
as percentage inhibition of prostaglandin biosynthesis. The results expressed as 
means ± standard errors are presented in Table 6.1. In this report, minimum 
inhibitory activity of ≥ 50% was considered as good inhibition of COX enzymes 
(ELDEEN and VAN STADEN, 2008). The inhibition of COX-1 enzyme causes 
significant damage to the gastro-intestinal tract such as bleeding and stomach 
ulcers (KIM et al., 2005). Therefore it is desirable to obtain plant products that are 
COX-2 selective. Plant extracts were first screened at a maximum concentration of 
250 µg/ml. Good percentage inhibition of COX-2 enzyme was thereafter used for 
the selection of plant extracts that were further evaluated at concentrations of 125 
and 62.5 µg/ml for both enzymes. At a concentration of 250 µg/ml (Table 6.1), 
virtually all the plant extracts showed stronger inhibition of COX-1 than COX-2. 
Plant extracts were considered to be COX selective because they inhibited either 
COX-1 or COX-2 enzyme at a percentage inhibition of prostaglandin of ≥ 50%. 
Inhibition of COX enzymes were observed mostly in the PE and DCM extracts of 
the evaluated plants. PE and DCM extracts from all the plant material (except 
Antidesma venosum leaves and Protea simplex bark) showed good COX-1 and 
COX-2 inhibition ranging from 60.6 to 103%. Generally, all the ethanol extracts 
(except Diospyros lycioides leaves and Watsonia tabularis corms extracts) showed 
weak or no activity against COX-2. However, COX-1 inhibition was exhibited by 
some EtOH extracts of the investigated plants with the exception of the EtOH 
extracts of Agapanthus campanulatus (leaves and roots), Becium obovatum 
(leaves), Cucumis hirsutus (leaves), Haworthia limifolia (leaves) and Protea 
simplex (leaves).  All the plant extracts of Cyperus textilis (leaves) showed 
selective COX-1 inhibitory activity ranging from 61.3 to 91.7%. At a concentration 
of 250 µg/ml, water extracts showed poor or no inhibitory activity against both 
enzymes. Interestingly water extracts from Agapanthus campanulatus (leaves), 
Becium obovatum (leaves), Cyperus textilis (roots), Protea simplex (leaves and 
bark) and Watsonia tabularis (corms) showed moderate to high activity against 
COX-1 enzyme with percentage inhibitory activity ranging from 50.3 to 90.5%. 
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Furthermore, most of the plant extracts evaluated at other lower concentrations 
(125 and 62.5 µg/ml) showed dose dependent activity against COX-1 and COX-2 
enzymes. However, Diospyros lycioides leaf PE extract (COX-1) (Figure 6.1a), 
Gladiolus dalenii corm PE, Diospyros lycioides stem PE, Vernonia natalensis leaf 
DCM, Agapanthus campanulatus root DCM, Becium obovatum root DCM as well 
as Watsonia tabularis corm EtOH extracts (COX-2) (Figure 6.1b) did not show 
dose response activities. At the lowest screening concentration (62.5 µg/ml), 
46.7% of the evaluated plant extracts screened showed non-selective inhibitory 
activity, 23% were COX-1 selective, while 6.7% were COX-2 selective with 
percentage inhibition of prostaglandins ≥ 50%. The highest COX-1 inhibition at a 
concentration of 62.5 µg/ml was exhibited by Diospyros lycioides leaf PE extract 
(89.1%) while Agapanthus campanulatus root DCM extract showed the highest 
COX-2 inhibitory activity (83.7%) at the same concentration.  
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Table 6.1: Anti-inflammatory activity (COX-1 and COX-2) of plant extracts evaluated at concentration of 250 μg/ml   








PE DCM EtOH Water   PE DCM EtOH Water 
Agapanthus campanulatus L 92.6  ± 1.1 78.4 ± 7.2 12.8 ± 0.8 74.2 ± 5.9 
 
72.3 ± 9.1 68.1 ± 3.8 16.9 ± 9.5 47.5 ± 3.7 
 
R 97.7 ± 1.4 98.4 ± 1.0 48.1 ± 9.3 33.4 ± 3.3 
 
78.0 ± 4.4 97.0 ± 1.2 9.1 ± 21.0 28.8 ± 4.0 
Antidesma venosum L 103.0 ± 0.8 72.8 ± 4.3 84.3 ± 7.0 36.2 ± 6.1 
 
46.6± 12.3 40.9 ± 9.9 40.9 ± 10.5 0 
Becium obovatum R 78.5 ± 4.0 86.4 ± 2.6 4.1 ± 3.0 85.3 ± 1.9 
 
76.6 ± 0.8 62.6 ± 9.3 0 1.2 ± 17.0 
Cucumis hirsutus L 91.7 ± 2.1 101.8 ± 1.1 29.1 ± 5.0 26.0 ±  9.4 
 
80.3 ± 3.5 81.5 ± 4.1 0 0 
Cyperus textilis R 91.7 ±  5.0 88.5 ±  4.9 81.4 ±  8.9 61.3 ± 0.69 
 
75.6 ± 9.8 73.5 ± 2.4 47.9 ± 24.3 0 
 
L 86.3 ±  0.7 88.4  ±  0.5 79.8 ±  8.9 0 
 
75.0 ± 1.8 83.0 ± 0.1 32.8 ± 1.0 0 
Diospyros lycioides L 92.8 ± 0.9 94.0 ±  5.7 90.4 ±  4.3 37.1 ± 0.2 
 
91.6 ± 1.9 84.8 ± 1.3 72.0 ± 2.3 0 
 
S 73.8 ± 3.6 81.0 ± 2.1 70.6 ± 1.2 13.1 ± 5.7 
 
67.7 ± 0.3 65.9 ± 1.7 37.9 ± 10.1 0 
Dissotis  princeps L 58.8 ± 1.2 82.7 ± 2.3 87.1 ± 4.0 4.8 ± 2.8 
 
60.6 ± 7.7 67.2 ± 9.5 22.1 ± 1.1 0 
Gladiolus dalenii C 88.3 ± 1.5 101.8 ± 0.3 53.1 ± 4.4 34.4 ± 0.1 
 
68.4 ± 5.7 100.6 ±3.5 35.6 ± 5.7 0 
Haworthia limifolia L 88.3 ± 3.8 83.5 ± 1.9 1.3 ± 4.1 30.7 ± 10.5 
 
82.4 ± 2.3 72.3 ± 2.8 0 0 
Protea simplex L 100.1 ± 0.8 80.6 ± 8.7 23.7 ± 6.1 57.8 ± 14.4 
 
72.4 ± 1.1 68.4 ± 3.7 0 20.9 ±  6.9 
 
B 94.2 ± 3.7 86.1 ± 7.1 89.2 ± 7.8 90.5 ± 1.2 
 
41.0 ± 7.4 35.8 ± 2.4 20.0 ± 2.1 16.7 ± 0.3 
Vernonia natalensis L 88.5 ± 3.2 77.5 ± 3.4 51.2 ± 12.4 38.7 ± 3.3 
 
86.7 ± 0.9 63.4 ± 0.5 0 0 
Watsonia tabularis C 97.6 ± 5.3 73.9 ± 5.1 90.3 ±  3.4 50.3 ± 1.8   91.5 ± 0.9 80.5 ± 8.7 51.1 ± 8.8 0 
Percentage inhibition of prostaglandin synthesis by indomethacin was 70 ± 3.3 for COX-1 and 68.9 ± 2.5 for COX-2. 














Figure 6.1a: Dose-dependent COX-1 percentage inhibition by different plant 
extracts.  
 
(A) Petroleum ether extracts, (B) Dichloromethane extracts and (C) Ethanol extracts.  
 
A.c = Agapanthus campanulatus; B.o = Becium obovatum; C.h = Cucumis hirsutus; 
C.t = Cyperus textilis; D.l = Diospyros lycioides; D.p = Dissotis princeps; G.d = 
Gladiolus dalenii; H.l = Haworthia limifolia; P.s = Protea simplex; V.n = Vernonia 
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Figure 6.1b: Dose-dependent COX-2 percentage inhibition by extracts plant 
species used for the treatment of gastro-intestinal infections.  
 
(A) Petroleum ether extracts, (B) Dichloromethane extracts and (C) Ethanol 
extracts.  
 
A.c = Agapanthus campanulatus; B.o = Becium obovatum; C.h = Cucumis 
hirsutus; C.t = Cyperus textilis; D.l = Diospyros lycioides; D.p = Dissotis princeps; 
G.d = Gladiolus dalenii; H.l = Haworthia limifolia; P.s = Protea simplex; V.n = 
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The evaluated plant species are used traditionally for the treatment of 
inflammation of the gastro-intestinal tract characterised by stomach pains, cramps, 
diarrhoea, dysentry and general stomach troubles. Inhibition of the biosynthesis of 
inflammatory mediators by blocking the activities of enzymes would be an 
important treatment of many inflammatory disorders (ZSCHOCKE and VAN 
STADEN, 2000). Some of these symptoms are treated clinically with pain relievers 
such as codeine phosphate (SLEIGH and TIMBURY, 1998). At least one extract 
from most the evaluated plant species showed good COX-1 and or COX-2 
inhibitory  activity with the percentage inhibition ≥ 50% at the maximum screening 
concentration with exception of Antidesma venosum and Protea simplex bark that 
are COX-1 selective. Plant medicinal compounds such as flavonoids and its 
derivatives, sterols, tocopherol, ascorbic acid, alkaloids, tannins, saponins, 
anthraquinones, triterpenoids, curcumin, genistein, and others have inhibitory 
properties on the molecular targets of pro-inflammatory mediators in inflammatory 
responses (IWALEWA et al., 2007).  
 
No anti-inflammatory study has been reported on the evaluated medicinal plants 
although some medicinal bioactive compounds with anti-inflammatory properties 
have been isolated from some of them. Haworthia species are reported to contain 
anthraquinones (HUTCHINGS et al., 1996). A range of anthraquinones are 
cathartic, antimicrobial and have anti-inflammatory properties (IWALEWA et al., 
2007). The inhibition of COX-1 and COX-2 enzymes with percentage inhibition of 
prostaglandins (> 50%) by some of H. limifolia leaf extracts could be attributed to 
the presence of anthraquinones in the plant species. The roots of Agapanthus 
species are reported to contain saponins and sapogenins of the furistane and 
spirostane types that have many biological activities and biochemical targets such 
as anti-inflammatory properties (VAN WYK et al., 1997; POLYA, 2003; 
IWALEWA et al., 2007). A. campanulatus root PE extract inhibited the COX-2 
enzyme with activity of 54.9%. The root DCM extract of the same plant inhibited 
COX-1 and COX-2 enzymes with activity of 82 and 83.7% respectively.  Cyperus 
species are reported to contain cineole, hydrocyanic acid and myristic acid 
(POLYA, 2003). These compounds could be attributed to the activity shown by the 
C. textilis leaf PE and DCM extracts against COX-1 and COX-2 at a concentration 
of 62.5 µg/ml. Bioactive medicinal compounds such as cucumin and γ-linolenic 
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acid, are reported to be present in  Curcubitaceae (VAN WYK et al., 1997; 
IWALEWA et al., 2007). Naphthalene glycosides, diospyrosides (A, B, C, and D) 
and two known bioactive naphthoquinones, juglone and 7-methyljuglone are 
reported in D. lycioides (LINING et al., 2000). The activity of D. lycioides leaf PE 
and DCM extracts against COX-1 (ranging from 73.9 to 79.3%) and COX-2 
(ranging from 51.2 to 63.1%) at a concentration of 62.5 µg/ml could be attributed 
to the bioactivity of some of the compounds as they are reported to have biological 
activities such as anti-inflammatory properties (POLYA, 2003). Interestingly, the 
stem PE extract of the same plant showed COX-2 selective activity of 65.3% at a 
concentration of 62.5 µg/ml.  
 
The anti-inflammatory activity showed by some of the evaluated plants supports 
their traditional uses in South African traditional medicine. In the human 
inflammatory process, anti-inflammatory activity of medicinal plants could be 
manifested in the inhibition of nuclear transcriptase factor (NFкB) mediated 
signalling pathway in immune cells that lead to the production of inducible nitric 
oxide synthase (iNOS), pro-inflammatory cytokines and inducible cyclooxygenase 
(iCOX). Inhibitor кB kinase (IкB) leads to NFкB de-inhibition, nuclear translocation 
and expression of pro-inflammatory proteins such as iCOX. Various plant 
compounds are responsible for the inhibition of inhibitor кB kinase (IкB), thus 
preventing NFкB activation and expression of pro-inflammatory proteins such as 
cytokines, COX and iNOS (POLYA, 2003). 
 
Plant decoctions are prepared with water in traditional medicine. In case of 
extracts showing weak or no activity in these assays, it will be noteworthy to 
mention that high dosage is often used in traditional medicine. Moreover, some of 
these extracts might be active at other sites in the inflammatory pathways and or 
contain compounds showing better activity in vivo as they undergo metabolic 










Anti-inflammatory activity observed with some of the investigated plant extracts in 
this study is interesting. Non-steroidal anti-inflammatory drugs NSAIDs that are 
COX-2 selective human are highly sought after by pharmaceutical companies. For 
the purpose of novel drug discovery, further studies aimed isolating and identifying 
active compounds are necessary. Isolated compounds from the evaluated 
traditional plants could be effective against other enzyme such as lipoxygenase 
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7.1    Introduction 
 
Plant secondary metabolites are compounds that have no recognised role in the 
maintenance of fundamental life processes in the plants that synthesize them, but 
they have important roles in the interaction of the plant with its environment 
(NEMDEO, 2007). Secondary metabolites in plants comprise a long list of 
compounds produced at various steps in the metabolic pathway that are not 
directly related to regulating photosynthesis or other primary metabolic pathways, 
such as respiration  (COLEY et al.,1985). The production of these compounds is 
often low and dependent on the physiological stages of plants (DIXON, 2001). A 
diversity of chemical compounds serves to defend plants. In some plants, the 
defensive chemical also routinely serves a number of functions, while in other 
cases a plant uses different chemicals under different stress conditions (JONES 
and COLEMAN, 1991). Although plant secondary products are very common, not 
all plants can produce every product. Some compounds are restricted to single 
species, others to related genus. But they are nearly always found only in certain 
specific plant organs, often in just one type of cell or cell organelle. Furthermore, 
they are often generated only during a specific developmental period of the plant. 
Some of the secondary metabolites (chemical substances) are biologically active 
and have phyto-pharmaceutical uses. Common secondary metabolites include 
alkaloids, phenols, tannins, glycosides, terpenoids, saponins, steroids and 
essential oils. During the last 20 to 30 years, the analysis of secondary plant 
products has advanced a lot with the use of modern analytical techniques like 




7.1.1   Properties of Some Plant Secondary Metabolites 
 
7.1.1.1   Alkaloids 
Alkaloids are a group of nitrogen-containing bases. The large majority are 
produced from amino acids, while only a few are derived from purines or 
pyrimidines. In a given plant, the concentration of alkaloids can vary widely from 
part to part, and some parts may contain none. Generally, alkaloids as bases are 
not soluble or sparingly soluble in water but are soluble in acidic solutions. 
Different alkaloids may also be found in different parts of the same plant. Alkaloids 
are widespread in plants and include some very well-known poisons, notably 
(coniine and strychnine), hallucinogens (morphine, cocaine and muscimol) and 
other potentially lethal compounds that are nevertheless used in medical practice 
(atropine, codeine, colchicine and morphine) (BRUNETON, 1995; POLYA, 2003). 
Atropine is a CNS stimulant and is used as a treatment for nerve gas poisoning. 
Scopolamine, another member of this class is used as a treatment for motion 
sickness. Alkaloid from Erythroxylum coca (cocaine) is also a central nervous 
system (CNS) stimulant, and has been used as a topical anaesthetic in 
ophthalmology. A similar compound is also contained in Datura stramonium 
(POLYA, 2003). The morphine alkaloids derived from the opium poppy, Papaver 
somniferum are powerful pain relievers and narcotics. Other useful alkaloids 
include agents to treat fibrillation (quinidine), antibacterial (berberine), and 
amebicide (emetine) (BRUNETON, 1995). 
 
7.1.1.2   Phenols 
The term phenolic acid applies to all compounds with at least one carboxyl group 
and one phenolic hydroxyl group. Plant phenolics represent a very large group of 
defensive compounds defined as having a phenol moiety. The phenolics range in 
complexity from simple phenolics and quinines, through chalcones and stilbenes 
to a range of phenolics with three rings namely anthocyanins, anthochlors, 
benzofurans, chromones, chromenes, coumarins, flavonoids, isoflavonoids, 
neoflavonoids, stilbenoids and xanthones. More complex polycyclic phenolics 
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exist, notably the hydrolysable tannins and condensed tannins. Notable simple 
phenol-related odorants include 4-methoxybensaldelhyde, guaiacol, 4-
hydroxybenzaldehyde, phenethyl alcohol, piperonal and vanilla. Some simple 
phenolics inhibit cyclooxygenate (COX) enzymes and 5-lipoxygenase (5-LOX), 
and have antibacterial and antifungal properties, particularly against 
phytopathogenic organisms (BRUNETON, 1995; POLYA, 2003).  Some known 
phenolic-containing plants include Cynara scolymus, Rosmarinus officinalis, 
Orthosiphon stamineus, Filipendula ulmaria, Salix alba, Solidago virga-aurea, 
Myroxylon balsamum and Lithospermum officinale (BRUNETON, 1995). 
 
7.1.1.3   Tannins 
 
Historically, the importance of tannin-containing drugs is linked to their tanning 
properties, which is their ability to transform fresh hides into imperishable leathers. 
In higher plants, hydrolysable and condensed tannins are the two groups of 
tannins that are generally distinguished based on their structure, as well as their 
biogenetic origin. Hydrolysable tannins are esters of a sugar and of a variable 
number of phenolic acid molecules, while condensed tannins or proanthocyanidins 
are polymeric flavans. Tannins dissolve in water to form colloidal solutions, but 
their solubility varies with their degree of polymerization. Most of the biological 
properties of tannins are linked to their ability to form complexes with 
macromolecules, particularly with protein. Externally, they waterproof the external 
layers of the skin and the mucosas, thus protecting the underlying layers. They are 
also known to have anti-diarrhoeal properties. They also have vasoconstrictor 
effects on small superficial vessels, and enhance tissue regeneration in case of 
superficial wounds or burns by limiting fluid losses and preventing external 
aggressions. Other tannin-containing plants include Quercus infectoria, Krameria 
lappacea, Lythrum salicaria, Acacia catechu, Crataegus monogyna and 








7.1.1.4   Saponins 
 
Saponins are a large form of glycosides present in plants. Saponins can be 
classified into two groups based on the nature of their aglycone. The first group 
consists of the steroidal saponins, which are almost exclusively present in the 
monocotyledonous angiosperms. Triterpenoid saponins consist of the second 
group which are the most common and occur mainly in the dicotyledonous 
angiosperms. Some authors distinguish a third category of saponins, namely the 
steroidal amines which are treated by others as steroidal alkaloids (BRUNETON, 
1995). Saponins are water soluble, have detergent properties, and can be 
haemolytic through solubilising the cell membrane of red blood cells. Many 
saponin-containing drugs are traditionally used for their antitussive and 
expectorant properties. Several drugs owe their anti-inflammatory and anti-edema 
activities to saponins (BRUNETON, 1995; LI et al., 2002; IWALEWA et al., 2007). 
Triterpenoid saponins from Chenopodium quinoa have been reported to have 
antifungal activity (WOLDEMICHAEL and WINK, 2001). Saponins from Ivy wood 
have also been reported to have antibacterial and anti-amoebic properties. They 
also have toxic effect on molluscs (BRUNETON, 1995; KILLEEN, et al., 1998; 
KINJO et al., 2000). Some known saponin-containing plants include Dioscorea 
species, Agave sisalana, Glycyrrhiza glabra, Ruscus aculeatus and Ranunculus 
ficariaI (BRUNETON, 1995). 
 
7.2   Thin Layer Chromatography (TLC) 
 
Thin layer chromatography (TLC) is a rapid method of drug analysis that can be 
used to efficiently demonstrate the characteristic constituents of a drug or raw 
plant extract. The technique clearly illustrates differences in chemical composition 
of plant extracts. TLC also enables the quantitative and qualitative detection of 
known natural products, and the associated metabolites or breakdown products. 
The use of photographic plates with a suitable solvent combination can be used to 
develop catalogue spectra of different compounds. The use of stain reagents can 
facilitate secondary metabolites identification (WAGNER and BLADT, 1996; VAN 
MIDDLESWORTH and CANNELL, 1998). 
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7.3   Materials and Methods 
7.3.1   Sample Preparation 
 
Evaluated medicinal plants were oven-dried at 50 ºC, ground into powders and 




7.3.2    Extraction of Plant Material 
 
Ground plant materials (5 g) were sequentially extracted with 100 ml of petroleum 
ether (PE), dichloromethane (DCM) and 70% ethanol (EtOH) in a sonication bath 
for 1 h (Julabo GMBH, West Germany) at room temperature with the temperature 
being cooled by adding ice. All the extracts were filtered under vacuum through 
Whatman No.1 filter papers in Bϋchner funnels and concentrated using Bϋchner 
rotary evaporator in vacuo at 30 ºC. The resultant extracts from the rotary 
evaporator were transferred to weighed pill vials and completely dried under a 
stream of air. Dried extracts were kept in the dark at 10 ºC for 72 h.  
 
 
7.3.3    TLC Fingerprinting 
 
Ten µl of PE, DCM and EtOH plant extracts (50 mg/ml) were loaded on thin layer 
chromatographic (TLC) plates (5 x 20 cm Silica gel, 60 F254) (Merck, Germany). 
The plates were developed using hexane:benzene:ethyl acetate (5:2:3 v/v/v) for 
PE and DCM extracts, while ethyl acetate:methanol:water (100:16.5:13.5 v/v/v) 
was used for EtOH extracts. After developing the fingerprints over a distance of 
7.5 cm, the plates were dried and viewed under ultraviolet (254 and 366 nm) and 
the photographs of the fluorescent bands were taken to compare the extracts 
fingerprints. Presence of phenolic compounds in the plant extracts was detected 
by spraying the plates with 1 N Folin-Ciocalteu reagent (MUCHUWETI et al., 
2006). After 60 min, the spots were visible and the plates were scanned using a 




7.3.4   Phytochemical Analysis 
 
7.3.4.1   Extraction of Phenolic Compounds 
 
Extraction of plant materials was done as described by MAKKAR (1999). Dried 
plant samples (2 g) were extracted with 10 ml of 50% aqueous methanol by 
sonication at room temperature for 20 min. All the extracts were filtered in vacuo 
through Whatman No.1 filter papers in Bϋchner funnels and transferred into pill 
vials for analysis. 
 
 
7.3.4.2   Folin Ciocalteu Assay for Total Phenolics 
 
The Folin Ciocalteu (Folin C.) assay was done as described by MAKKAR (1999) 
with slight modification. In triplicate, each extract (50 µl) was transferred into test 
tube and made up to 1 ml with distilled water (950 µl), followed by the addition of 1 
N Folin C. reagent (500 µl) and 2% sodium carbonate (2.5 ml). A similar 
preparation of a blank control containing aqueous methanol instead of plant 
extracts, and concentrations of gallic acid (Appendix) were made. The test 
mixtures were incubated for 40 min at room temperature then absorbance read at 
725 nm using a UV-spectrophotometer. Total phenolics were expressed as gallic 
acid (GAE) equivalents. Biostatistical analysis was done using Graphpad prism 
(Graphpad software incorporation). 
 
 
7.3.4.3   The Butanol-HCl Assay for Condensed Tannins 
 
In triplicate, 3 ml of butanol-HCl (95:5 v/v) reagent was added to plant extracts 
(500 µl), followed by 100 µl ferric reagent (Appendix). The test solutions were 
vigorously mixed using a vortex mixer (Chiltern) and heated in a water bath at 100 
ºC. After 60 min, absorbance at 550 nm was measured using a UV-
spectrophotometer against a blank prepared by mixing tannin-containing extract 
(500 µl) with butanol reagent (3 ml) and ferric reagent (100 µl), but without heating. 
Condensed tannins (% per dry matter) as leucocyanidin equivalents were 
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calculated using the formula: (A550 nm X 78.26 X dilution factor) ∕ (% dry matter), as 
described by PORTER et al. (1986). Biostatistical analysis was done using 
Graphpad prism (Graphpad software incorporation). 
 
 
7.3.4.4   Rhodanine Assay for Gallotannins 
 
Plant extracts (50 µl) were made up to 1 ml with distilled water in triplicate. To the 
diluted extracts, 100 µl of 0.4 N sulphuric acid and rhodanine (600 µl) were added. 
After 5 min, 200 µl potassium hydroxide (0.5 N) (Appendix) was added, and 
distilled water (4 ml) after 2.5 min. Concentrations of gallic acid (Appendix) were 
made. After a further 15 min at room temperature, absorbance at 520 nm was 
read using a UV-visible spectrophotometer (Varian) against a blank test that 
contained methanol instead of sample. Gallotannins were expressed as gallic acid 
(GAE) equivalents (MAKKAR, 1999). 
 
 
7.3.4.5   Vanillin Assay for Flavonoids 
 
Plant extracts (50 µl) were made up to 1 ml with distilled water in test tubes before 
adding 2.5 ml of methanol-HCl (95:5 v/v) and finally 2.5 ml vanillin reagent (1 
g/100 ml distilled water). Similar preparations of blank controls that contained 
methanol instead of plant extracts, and concentrations of catechin (4 mg/ml) 
(sigma) were made. The test tubes were left for 20 min at room temperature 
before absorbance at 500 nm was read using a UV- visible spectrophotometer 
against the blank. Plant extracts and controls were assayed in triplicate. The 
flavonoids in the plant extracts were expressed as catechin equivalents 
(MAKKAR, 1999). Biostatistical analysis was done using Graphpad prism 








7.3.4.6   Thin Layer Chromatography for Alkaloid Detection 
 
Ten microlitres each of PE, DCM and EtOH plant extracts (50 mg/ml) (prepared as 
described in Section 7.2.2) were loaded on thin layer chromatographic (TLC) 
plates (5 x 20 cm Silica gel, 60 F254) (Merck, Germany). The plates were 
developed using hexane:benzene:ethyl acetate (5:2:3 v/v/v) for PE and DCM 
extracts, while ethyl acetate:methanol:water (100:16.5:13.5 v/v/v) was used for 
EtOH extracts. After developing the fingerprints over a distance of 7.5 cm, the 
plates were dried and viewed under UV light (UV254 and UV366 nm). The 
photographs of the fluorescence were taken before being sprayed with modified 
Dragendorff reagent (Appendix) to detect the presence of alkaloids (ROBERT, 
1962; WILFRED and RALPH, 2006). After 10 min, the spots were visible and the 
plates were scanned using a high resolution Hp scan jet 7400 scanner. 
 
 
7.3.4.7   Froth Test for Saponins 
 
Ten ml of distilled water were added to 0.1 g of ground plant sample in test tubes 
in duplicate. The test tubes were corked and vigorously shaken for 2 min. The 
appearance of stable foam or froth (3 cm high from the surface of water) for 45 
min showed the presence of saponins. Presence of saponins was further tested by 
taking aqueous extract (2 ml) into a test tube, followed by adding olive oil (10 
drops). The test tube was corked and vigorously shaken. The forming of an 
emulsion confirmed the presence of saponins (TADHANI and SUBHASH, 2006). 
 
 
7.4   Results and Discussion 
 
7.4.1   TLC Fingerprinting 
 
Comparing the distance moved by the plant extract components and different 
colours on the TLC chromatogram (Figure 7.1), it can be suggested that some 
extracts contained different compounds. Under UV254nm, most of the bands 
appeared blue-green inflorescence at different Rf values. However, under UV366nm, 
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colours ranging from deep red to blue fluorescence were observed (Figure 7.2). 
Phenolic compounds appeared blue-black on the plates after spraying with Folin 
Ciocalteu reagent (Appendix). Phenolic compounds were detected at differing 
colour intensity on the TLC chromatogram in all of the plant extracts (Figure 7.3). 
Variation in the intensity of the colour (blue-black) of the phenolic compositions 
after spraying with Folin C. reagent suggests that the amounts present in some 
plant extracts varied with plant parts, extracts and species. More phenolic 
compounds are contained in DCM extracts of most of the plant materials. The 
pharmacological activities exhibited by some of the plant extracts could be 















Figure 7.1: TLC Fingerprinting profiles of (A) PE extracts, (B) DCM extracts and 
(C) EtOH extracts of investigated plant species viewed under UV 254 nm.  
PE and DCM extracts were developed with hexane:benzene:ethyl acetate (5:2:3 
v:v:v), EtOH extracts were developed with ethyl acetate:methanol:water 
(100:16.5:13.5 v:v:v). 
 
1- Haworthia limifolia (leaf), 2- Cucumis hirsutus (leaf), 3- Becium obovatum (root), 
4- Protea simplex (leaf), 5- P. simplex (bark), 6- Agapanthus campanulatus (leaf) 
7- A. campanulatus (root), 8- Cyperus textilis (root), 9- C. textilis (leaf), 10- 
Vernonia natalensis (leaf), 11- Watsonia tabularis (corm), 12- Antidesma venosum 
(leaf), 13- Diospyros lycioides (leaf), 14- D. lycioides (stem), 15- Dissotis  princeps 




Figure 7.2: TLC Fingerprinting profiles of (A) PE extracts, (B) DCM extracts and 
(C) EtOH extracts of investigated plant species viewed under UV 366 nm.  
 
PE and DCM extracts were developed with hexane:benzene:ethyl acetate (5:2:3 
v:v:v), EtOH extracts were developed with ethyl acetate:methanol:water 
(100:16.5:13.5 v:v:v). 
 
1- Haworthia limifolia (leaf), 2- Cucumis hirsutus (leaf), 3- Becium obovatum (root), 
4- Protea simplex (leaf), 5- P. simplex (bark), 6- Agapanthus campanulatus (leaf) 
7- A. campanulatus (root), 8- Cyperus textilis (root), 9- C. textilis (leaf), 10- 
Vernonia natalensis (leaf), 11- Watsonia tabularis (corm), 12- Antidesma venosum 
(leaf), 13- Diospyros lycioides (leaf), 14- D. lycioides (stem), 15- Dissotis  princeps 




Figure 7.3: TLC Fingerprinting profiles of (A) PE extracts, (B) DCM extracts and 
(C) EtOH extracts of investigated plant species.  
Presence of phenolic compounds (blue-black) was detected by spraying with Folin 
C reagent.  
1- Haworthia limifolia (leaf), 2- Cucumis hirsutus (leaf), 3- Becium obovatum (root), 
4- Protea simplex (leaf), 5- P. simplex (bark), 6- Agapanthus campanulatus (leaf) 
7- A. campanulatus (root), 8- Cyperus textilis (root), 9- C. textilis (leaf), 10- 
Vernonia natalensis (leaf), 11- Watsonia tabularis (corm), 12- Antidesma venosum 
(leaf), 13- Diospyros lycioides (leaf), 14- D. lycioides (stem), 15- Dissotis  princeps 
(leaf), 16- Gladiolus dalenii (corm). 
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7.4.2   Total Phenolic Compositions 
 
The results of the total phenolic contents of the investigated plant species are 
presented in Figure 7.4. The largest amount of total phenolics is contained in C. 
textilis (leaves) (84.5 mgGAE/g). B. obovatum (root), P. simplex (leaves and bark), 
and C. textilis (roots) contained total phenolics ≥ 50 mgGAE/g. Phenolic 
compounds are of important pharmacological values which include antibacterial, 
antifungal and anti-inflammatory activities. All the plant materials evaluated 
showed considerable amounts of phenolic compounds that could in one way or 
another be attributed to the pharmacological activities observed (FRANKEL et al., 
1993; HARBORNE, 1994; SHARMA et al., 1994; POLYA, 2003). It is however 
noted that the plant extracts with high phenolic contents showed moderate to high 
antibacterial, antifungal and anti-inflammatory activities. This suggests that the 
quality of the phenolic compounds also plays a major role. Therefore investigation 
of specific phenolic compounds such as flavonoids, gallotannins and condensed 




7.4.3   Condensed Tannin Contents 
 
Figure 7.5 showed the amounts of condensed tannins expressed as percentage 
dry matter. Condensed tannins are measured as leucocyanidins (flavan-3, 4-diol) 
equivalents which are the products of the breakdown of condensed tannins in the 
assay (SHARON et al., 2002; CROZIER et al., 2006). Highest amounts (4.13%) of 
condensed tannins were detected in C. textilis (leaves), while low levels were 
detected in G. dalenii (corms). No condensed tannins were detected in B. 
obovatum (roots), A. campanulatus (roots) and V. natalensis (leaves). Condensed 
tannins have been reported to accumulate in root and leaf tissues of many plants, 
probably as a defence mechanism against microbes (BRUNETON, 1995). The 
root and leaf extracts of C. textilis showed why the observed pharmacological 
activity could be attributed to the condensed tannins detected here. Condensed 
tannins (proanthocyanidin) essentially contained (+) gallocatechin, (–) epicatechin, 
(+) catechin and epigallocatechin, and their derivatives via carbon-carbon links. 
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These compounds are primarily responsible for inhibiting the generation of 
chemiluminescence by activated human polymorphonuclear neutrophil (PMN), 
indicating that these compounds inhibit the oxidative burst of PMN during 
inflammation (POLYA, 2003).  
 
 
7.4.4   Gallotannins Contents 
 
The assay is based on the hydrolysis of gallotannins to gallic acid. Gallic acid 
reacts with the rhodanine to give an intense colour that can be measured using a 
spectrophotometer. Figure 7.6 presents the amounts of gallotannins detected in 
the investigated 12 medicinal plants. Gallotannins were detected in all of the 
investigated plant species with the exception of A. campanulatus (roots) and G. 
dalenii (corms). The largest amounts of gallotannins were detected in P. simplex 
(leaves) (13.5 µg/g of dry matter). Relatively high amounts of gallotannins were 
also detected in D. lycioides and D. princeps leaves. Gallotannins have been 
reported to exert various biological effects ranging from antimicrobial to anti-
inflammatory and anticancer (ERDE`LYI et al., 2005). The mechanisms underlying 
the anti-inflammatory effect of gallotannins include the scavenging of radicals and 
inhibition of the expression of inflammatory mediators, such as some cytokines, 
inducible nitric-oxide synthase, and cyclooxygenase-2 (POLYA, 2003; ERDE`LYI 
et al., 2005). This could possibly explain the best antibacterial and antifungal, as 
well as good anti-inflammatory activities exhibited by P. simplex. Pharmacological 
activities of other plant materials could in part be influenced by high amounts of 
gallotannins detected.  
 
 
7.4.5   Flavonoids Contents 
  
As shown in Figure 7.7, flavonoids were detected in all the evaluated plant 
species. The flavonoid content is represented as catechin equivalents. The highest 
amount (7.4 mg/g) of flavonoids was detected in C. textilis (leaves), while the 
lowest amount was detected in H. limifolia (0.24 mg/g). Several flavonoids and 
biflavonoids are potent inhibitors of lipoxygenase, or cyclooxygenase 
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(BRUNETON, 1995; POLYA, 2003). According to TALHOUK et al. (2007), 
flavonoids are known to act on the inflammatory response via many routes and 
block molecules like COX, iNOS, cytokines, nuclear factor-кB and matrix 
metalloproteinases. Some flavonoids have been reported to be effective against 
acute inflammation in vivo using a carrageenin-induced mouse paw oedema 
model (PELZER et al., 1998). 
 
Flavonoid could be major bioactive compounds responsible for the anti-
inflammatory properties exhibited by some extracts of C. textilis as well as other 
active extracts. Furthermore, flavonoids derivatives such as epicatechin, quercetin 
and luteolin are reported to inhibit the development of fluids that result in diarrhoea 
and abdominal pains. This could explain why these plant species are used in 

























































Figure 7.4: Total phenolics content as gallic acid equivalents detected in 
medicinal plants used for treating gastro-intestinal ailments in traditional medicine. 
 
DM – dry matter; GEA- gallic acid equivalents 
 
 1- Haworthia limifolia (leaf), 2- Cucumis hirsutus (leaf), 3- Becium obovatum 
(root), 4- Protea simplex (leaf), 5- Protea simplex (bark), 6- Agapanthus 
campanulatus (root), 7- Cyperus textilis (root), 8- Cyperus textilis (leaf), 9- 
Vernonia natalensis (leaf), 10- Watsonia tabularis (corm), 11- Antidesma venosum 
(leaf), 12- Diospyros lycioides (leaf), 13- Diospyros lycioides (stem), 14- Dissotis 









































Figure 7.5: Percentage of condensed tannins as leucocyanidins equivalents 
detected in medicinal plants used for treating gastro-intestinal ailments in 
traditional medicine. 
 
1- Haworthia limifolia (leaf), 2- Cucumis hirsutus (leaf), 3- Becium obovatum (root), 
4- Protea simplex (leaf), 5- Protea simplex (bark), 6- Agapanthus campanulatus 
(root), 7- Cyperus textilis (root), 8- Cyperus textilis (leaf), 9- Vernonia natalensis 
(leaf), 10- Watsonia tabularis (corm), 11- Antidesma venosum (leaf), 12- Diospyros 
lycioides (leaf), 13- Diospyros lycioides (stem), 14- Dissotis princeps (leaf), 15- 























































Figure 7.6: Gallotannins concentration as gallic acid equivalents detected in 
medicinal plants used for treating gastro-intestinal ailments in traditional medicine. 
DM – dry matter; GEA- gallic acid equivalents 
 
1- Haworthia limifolia (leaf), 2- Cucumis hirsutus (leaf), 3- Becium obovatum (root), 
4- Protea simplex (leaf), 5- Protea simplex (bark), 6- Agapanthus campanulatus 
(root), 7- Cyperus textilis (root), 8- Cyperus textilis (leaf), 9- Vernonia natalensis 
(leaf), 10- Watsonia tabularis (corm), 11- Antidesma venosum (leaf), 12- Diospyros 
lycioides (leaf), 13- Diospyros lycioides (stem), 14- Dissotis princeps (leaf), 15- 









































Figure 7.7: Flavonoid concentration as catechin equivalents detected in 
medicinal plants used for treating gastro-intestinal ailments in traditional medicine. 
DM – dry matter. 
 
1- Haworthia limifolia (leaf), 2- Cucumis hirsutus (leaf), 3- Becium obovatum (root), 
4- Protea simplex (leaf), 5- Protea simplex (bark), 6- Agapanthus campanulatus 
(root), 7- Cyperus textilis (root), 8- Cyperus textilis (leaf), 9- Vernonia natalensis 
(leaf), 10- Watsonia tabularis (corm), 11- Antidesma venosum (leaf), 12- Diospyros 
lycioides (leaf), 13- Diospyros lycioides (stem), 14- Dissotis princeps (leaf), 15- 
Gladiolus dalenii (corm). 
 
 
7.4.6   Alkaloid Detection 
 
Alkaloids produce orange-red colouration with Dragendorff reagent on TLC plates 
(ROBERT, 1962; WILFRED and RALPH, 2006). Alkaloids were detected in H. 
limifolia leaf (PE and EtOH), C. hirsutus leaf (EtOH), B. obovatum root (DCM), P. 
simplex root and bark (EtOH), A. campanulatus root (DCM) and leaf (EtOH), C. 
textilis root (DCM), V. natalensis leaf (PE), A. venosum leaf (PE), D. lycioides leaf 
(PE) and D. princeps leaf (DCM) (Figure 7.8). Alkaloids have been reported for A. 
venosum leaves (WATT and BREYER-BRANDWIJK, 1962; HUTCHINGS et al., 
1996). HUTCHINGS et al. (1996) and NDUKWE et al. (2004) have also reported 
alkaloids for Vernonia species and D. lycioides in preliminary tests. Alkaloids are 
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interesting substances because of their multiple pharmacological activities ranging 
from depressants or stimulants, sympathomimetics, sympatholtics and 
ganglioplegics. In addition, alkaloids include curare, local anaesthetics (cocaine), 
agents to treat fibrillation (quinidine), antitumor agents (vinblastine), antimalarials 
(quinine), antibacterial substances (berberine), and amebicides (emetine) 
(BRUNETON, 1995). Some alkaloids such as Isoquinoline,   indole and diterpene 
alkaloids are known to have good anti-inflammatory activity (BARBOSA-FILHO et 
al., 2006). The activity showed by extracts of plant species where alkaloids were 















Figure 7.8: TLC Fingerprinting profiles of (A) PE extracts (B) DCM extracts and 
(C) EtOH extracts of investigated plant species.  
 
Presence of alkaloids (red-orange) was detected by spraying with Dragendorff 
reagent.  
 
1- Haworthia limifolia (leaf), 2- Cucumis hirsutus (leaf), 3- Becium obovatum (root), 
4- Protea simplex (leaf), 5- P. simplex (bark), 6- Agapanthus campanulatus (leaf) 
7- A. campanulatus (root), 8- Cyperus textilis (root), 9- C. textilis (leaf), 10- 
Vernonia natalensis (leaf), 11- Watsonia tabularis (corm), 12- Antidesma venosum 
(leaf), 13- Diospyros lycioides (leaf), 14- D. lycioides (stem), 15-Dissotis  princeps 
(leaf), 16- Gladiolus dalenii (corm). 
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7.4.7   Saponin Detection 
 
Saponins display a creamy, even foamy texture that distinguishes them from other 
plant metabolites (POLYA, 2003). All of the evaluated plant samples (Table 7.1) 
with the exception of H. limifolia, P. simplex, A. venosum and D. princeps leaves 
tested positively for saponins. According to SPARG et al. (2004), many saponins 
extracted from plant sources produce an inhibition of inflammation in the mouse 
carrageenan-induced oedema assay and are also known to have antimicrobial, 
antifungal or antiyeast activities. The anti-inflammatory activities of some saponins 
derivatives such as triterpenoids saponins have been reported (SAHU and 
MAHATO, 1994). There could be a possible synergism among saponins and other 
active metabolites in the anti-inflammatory activity exhibited by some investigated 
plant extracts such as D. lycioides leaf and A. campanulatus root extracts where 















Table 7.1: Detection of saponins in the investigated medicinal plants used for  




































Cyperus textiles Leaves + 
 
Diospyros lycioides Leaves + 
 
Diospyros lycioides Stems + 
 
Dissotis  princeps Leaves - 
 
Gladiolus dalenii Corms + 
 
Haworthia limifolia Leaves - 
 
Protea simplex Leaves - 
 
Protea simplex Bark + 
 
Vernonia natalensis Leaves + 
 
Watsonia tabularis Corms + 
- = Absence of saponins 







7.5   Conclusions 
 
The results obtained on the phytochemistry of the plant species provide 
preliminary information on some important groups of plant principles that are 
present in the investigated plant species, and also suggest the types of plant 
bioactive compounds that may be responsible for the biological activities exhibited 
by some of the plant extracts. The investigated plants can be seen as potential 
sources of novel and useful drugs. Further studies to isolate and identify the plant 
principles from the medicinal plants will be considered in the future. It may also be 

































Thousands of plant species growing throughout the world have medicinal value, 
containing active constituents that have a direct action on the human body. In 
recent years, research to discover promising potential medicinal plants used in 
various traditional, complementary and alternative systems has attracted a lot of 
attention globally (BRUNETON, 1995). Several South African medicinal plants 
have been studied for pharmacological and phytochemical activities using modern 
scientific methodologies and tools in recent years. Research on twelve South 
African traditional medicinal plants used as antimicrobials presented in this thesis 
encompassed different areas of study that provide scientific information on the 
possible reasons why some of  the investigated medicinal plants are commonly 
used in traditional medicine. 
 
Three areas of study were focused on in this thesis. The pharmacology of the 
medicinal plants, which involved the extraction of dried medicinal plant materials 
with solvents ranging in polarity, and a broad evaluation of the extracts for 
antibacterial, antifungal, anti-inflammatory and mutagenic properties. Thin layer 
chromatographic (TLC) fingerprints of the evaluated plant extracts were developed 
to compare the compositions of the evaluated plant species. Finally, in the quest to 
understand the source of the plant pharmacological activities, total phenolic 
compounds including condensed tannins, gallotannins and flavonoids were 
quantitatively investigated in terms of their amounts in the aqueous methanol 
extracts of the medicinal plants.  
 
Agapanthus campanulatus leaves and roots exhibited a range of pharmacological 
and phytochemical properties. The leaf dichloromethane (DCM) extract exhibited 
interesting antibacterial activity (0.39 mg/ml) against Bacillus subtilis. However, 
70% ethanol extracts (EtOH) of both leaves and roots showed good antifungal 
activity with minimum concentration values of 0.29 and 0.39 mg/ml respectively. At 
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a concentration of 62.5 µg/ml, the leaf petroleum (PE) extract and the root DCM 
extract inhibited both cyclooxygenase-1 and cyclooxygenase-2 (COX-1 and COX-
2) enzymes with a percentage inhibition value greater than 50%. Genotoxicity test 
showed no positive results in active extracts of both plant parts. Phytochemistry 
screening revealed that A. campanulatus leaves and roots contain phenolic 
compounds, saponins, alkaloids and flavonoids. 
 
No interesting antifungal and anti-inflammatory activities were observed in 
Antidesma venosum. However, the leaf EtOH extract showed good antibacterial 
activity (0.65 mg/ml) against Staphylococcus aureus. The active extract showed 
no positive result in the Ames test.  Positive tests for condensed tannins, 
phenolics, alkaloids, flavonoids and gallotannins were detected in the plant 
species. 
 
A broad spectrum antibacterial activity was exhibited by Becium obovatum leaf PE 
extract against both Gram-negative and Gram-positive bacteria. However, no 
interesting antibacterial and antifungal activities were observed in the root. Anti-
inflammatory screening revealed some degree of COX-1 and -2 enzyme inhibition 
by the root non-polar extracts at a concentration of 250 µg/ml. No genotoxic 
properties were observed in the active extracts. The leaves were not evaluated in 
the phytochemical analysis due to lack of plant material. However, phenolics, 
saponins, alkaloids, flavonoids and gallotannins were detected in the root. 
 
Cucumis hirsutus leaf PE and DCM extracts showed a broad spectrum 
antibacterial activity however no antifungal activity was exhibited by any of the 
plant extracts. Leaf PE and DCM extracts indicated good anti-inflammatory activity 
against COX-1 and -2 enzymes with inhibitory concentration values greater than 
60% at a concentration of 62.5 µg/ml. Bioactive leaf extracts showed no 
genotoxicity in the Ames test. Phytochemical screening showed the presence of 
condensed tannins, phenolics, alkaloids, saponins, flavonoids and gallotannins in 
the leaves. 
 
Pharmacological evaluation of Cyperus textiles showed that root PE and DCM as 
well as leaf and root EtOH extracts inhibited Gram-positive bacteria at minimum 
inhibitory concentration values less than 1.0 mg/ml. No antifungal and genotoxic 
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activity was revealed in both the leaf and root extracts. COX-1 selective inhibition 
was exhibited by the root PE extracts at a concentration of 62.5 µg/ml. The 
phytochemistry of C. textiles showed the presence of alkaloids in the leaves. 
Saponins and large amounts of condensed tannins, phenolic compounds, 
flavonoids and gallotannins are present in both plant parts. 
 
Diospyros lycioides stem DCM extract showed good antibacterial activity. Non-
polar leaf extracts showed good anti-inflammatory activity against COX-1 and -2 
enzymes at a concentration of 62.5 µg/ml. Interestingly, the stem PE extract 
showed a COX-2 selective inhibitory activity at the same concentration. No 
genotoxic properties were observed in the active extracts. Phytochemical studies 
revealed the presence of alkaloids only in the plant leaves. However, condensed 
tannins, phenolic compounds, flavonoids, gallotannins and saponins are present in 
both plant parts. 
 
Dissotis princeps leaf EtOH and water extracts exhibited interesting antibacterial 
activity against Gram-negative and Gram-positive bacteria with a minimum 
inhibitory concentration of 0.78 mg/ml. The EtOH extracts also showed good 
antifungal activity with a MIC value of 0.014 mg/ml. COX-1 selective anti-
inflammatory activity was exhibited by the DCM extracts. Genotoxicity tests 
showed no positive result with all the plant extracts. D. princeps leaves tested 
positive to condensed tannins, phenolic compounds, saponins, flavonoids, 
gallotannins and alkaloids. 
 
The pharmacological analysis of Gladiolus dalenii corms showed good 
antibacterial activity of DCM extract with a MIC value of 0.39 mg/ml. The EtOH 
extract exhibited antifungal activity with the same MIC value. The highest COX-1 
and -2 percentage inhibition was observed with the non-polar extracts of the 
corms. No genotoxic properties were observed with the active extracts. 
Phytochemical screening of G. dalenii corms revealed the presence of phenolic 
compounds, flavonoids and saponins. 
 
Haworthia limifolia leaf PE extracts showed broad spectrum antibacterial activity 
with a minimum inhibitory concentration value less than 1.0 mg/ml. However, no 
interesting antifungal activity was exhibited by any of the plant extracts. Good 
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COX-1 and -2 inhibition was shown by leaf non-polar extracts with percentage 
inhibition greater than 50% at a concentration of 62.5 µg/ml. Genotoxicity 
screening revealed no cytotoxic effects in the active extracts. The pharmacological 
activities exhibited by H. limifolia could be as a result of condensed tannins, 
phenolics, flavonoids, gallotannins and alkaloids contained in the leaves. 
 
Protea simplex bark and leaf extracts showed interesting pharmacological 
activities. The leaf non-polar extracts showed a broad spectrum (and the best) 
antibacterial activity against Gram-negative and Gram-positive bacteria while the 
bark non-polar extracts, including the EtOH extract, showed activity against Gram-
positive bacteria. Good antifungal activity was exhibited by the leaf PE and DCM 
extracts with a minimum fungicidal concentration of 0.014 and 0.39 mg/ml 
respectively. Non-polar leaf extracts showed interesting COX-1 and -2 inhibition at 
a concentration of 62.5 µg/ml. No anti-inflammatory activity was exhibited by the 
bark extracts at the same concentration. Active extracts showed no positive tests 
in the Ames test. Phytochemical analysis revealed that the leaves tested 
negatively to saponins while the bark tested positively for saponins. Condensed 
tannins, phenolic compounds, alkaloids, flavonoids and gallotannins are 
apparently present in both plant parts. 
 
Vernonia natalensis leaf DCM extract inhibited Gram-positive bacteria. No 
interesting antifungal activity was observed by any of the extracts. Anti-
inflammatory screening revealed that non-polar leaf extracts showed good 
inhibition of COX-1 and -2 enzymes at a concentration of 62.5 µg/ml. No genotoxic 
properties were observed in the active extracts. Phytochemical screening 
indicated that alkaloids, flavonoids and gallotannins and phenolic compounds are 
contained in V. natalensis leaves. 
 
Watsonia tabularis corm non-polar extracts inhibited Gram-positive bacterial 
growth. No interesting antifungal activity was exhibited. Anti-inflammatory activity 
was observed by non-polar extracts against COX-1 and -2 enzymes. No genotoxic 
properties were observed in the active extracts. W. tabularis corms tested 




Plant extracts were loaded onto thin layer chromatographic (TLC) plates. The 
plates were developed using hexane:benzene:ethyl acetate (5:2:3 v/v/v) for PE 
and DCM extracts, while ethyl acetate:methanol:water (100:16.5:13.5 v/v/v) was 
used for EtOH extracts. After development, the plates were dried and viewed 
under UV (254,366 nm) and the photographs of the fluorescence were taken. 
Different coloured bands with varying Rf values were observed in some of the 
extract fingerprints suggesting that some of the extracts contain different plant 
compounds.  
 
The results presented in this thesis provide results of the investigation of medicinal 
plants which can lead to the isolation of pure biologically active components from 
the evaluated medicinal plants. With regards to the pharmacological and 
phytochemical studies of 10 plant families, isolation of active and effective 
antimicrobial plant ingredients from plant species belonging to the family 
Agapanthaceae, Melastomataceae, Iridaceae and Proteaceae are necessary. This 
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Ferric Reagent Recipe 
Ferric reagent is 2% ferric ammonium sulphate in 2 N HCl 
Solution A 
Make 16.6 ml of concentrated HCl up to 100 ml with distilled water to make 2 N 
HCl. 
 
Dissolve 2.0 g ferric ammonium sulphate in Solution A. The reagent should be 
stored in a dark bottle (MAKKAR, 1999). 
 
Gallic Acid Standard Solution 
Solution A 
100 mg gallic acid in 80 ml of 0.4 N sulphuric acid.  
 
Make Solution A up to 100 ml with 0.4 N sulphuric acids (can be stored for at least 
a month). 
Note: 95 to 98% commercially available sulphuric acid is approximately 36 N 
(MAKKAR, 1999). 
 
Modified Dragendorff Reagent Recipe 
Solution A 
0.85 g of bismuth subnitrate in glacial acetic acid: distilled water (10 ml: 40 ml).  
Solution B 
8 g of potassium iodide in 20 ml of distilled water.  
Solution C 
20 ml of glacial acetic acid and 100 ml of distilled water. 
Mix Solution A with Solution B and store in a bottle and keep away from light (wrap 
with aluminium foil). 
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Dilute 1 ml of the mixture before use with 2.3 ml of a mixture of Solution C. The 
reagent is stable for several weeks when protected from light. 
Add 1 ml of Solution A with 1 ml of Solution B, mix well and then add 2.3 ml of 20 
ml of glacial acetic acid in 100 ml of distilled water (ROBERT, 1962). 
 
 
Preparation of 0.5 N Potassium hydroxide Solution 
Dissolve 2.8 g potassium hydroxide in 100 ml distilled water (MAKKAR, 1999). 
 
Preparation of 1N Folin Ciocalteu Reagent  
Dilute commercially available Folin Ciocalteu (Folin C.) reagent (2 N). Add 5 ml of 
Folin C. reagent with 5 ml of distilled water. Store away from light in a refrigerator. 
Note: The reagent should be golden in colour (Do not use it if it turns olive green) 
(MAKKAR, 1999). 
 
